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Shock is defined as global tissue hypoxia secondary to an imbalance between 
systemic oxygen delivery (DO2) and oxygen demand (VO2). Unrecognized and untreated 
global tissue hypoxia increases morbidity and mortality. Accurate detection of global tissue 
hypoxia is therefore of vital importance. Physical findings, vital signs, measuring central 
venous pressure (CVP) and urinary output are important, but insufficient for accurate 
detection of global tissue hypoxia [1-3]. Measurement of mixed venous oxygen saturation 
(SvO2) from the pulmonary artery (PA) has been advocated as an indirect index of tissue 
oxygenation [4]. However, as a result of an extensive debate in literature [5-7], the use of the 
pulmonary artery catheter (PAC) has become, justifiable or not [8], somewhat unpopular. In 
contrast, insertion of a central venous catheter in the superior vena cava via the jugular or 
subclavian vein is considered standard care in critically ill patients. Just as SvO2, the 
measurement of central venous oxygen saturation (ScvO2) has been advocated as a 
derivative of global tissue hypoxia. Venous oxygen saturations have been subject of 
research for over fifty years, but especially over the last decade the amount of literature 
describing changes in ScvO2 and SvO2 in critically ill patients increased substantially.  
The main reason for the revival of interest in venous oxygen saturations was the 
publication of the so-called Early Goal-Directed Therapy (EGDT) study by Rivers et al [9]. In 
this study an impressive mortality reduction was achieved in favour of the patients treated 
according to the EGDT protocol which included ScvO2-guided therapy. This led to high 
expectations with respect to the use of central venous oxygen saturation as a therapeutic 
goal. In a strict sense the goal would be a ScvO2 value ≥70% which deems a lower ScvO2 at 
patient presentation. After a literature search on the clinical use of venous oxygen 
saturations in various settings, chapter 2 describes the occurrence of low ScvO2 and SvO2 
values in 340 critically ill patients at intensive care unit (ICU) admittance. Central question: is 
EGDT still commonly indicated as suggested by the Surviving Sepsis Campaign Guidelines 
[10], if a minority of septic patients reveals low venous oxygen saturations? 
The PAC, together with the defining variables it provides including SvO2, has been a 
fundamental hemodynamic monitoring tool in ICUs for over 40 years. Consequently, 
replacement of SvO2 by ScvO2 in diagnostic and therapeutic strategies asks not only for 
arguments but also for nuance. In other words, are both values equal or interchangeable, in 
septic shock especially, and is this clinically relevant? In chapter 3 the generally adopted 
difference of 5% between SvO2 and ScvO2 is addressed [11-13], also paying attention to the 
question on the use of both variables in patients with septic shock. 
In clinical practice, when insertion of a central venous catheter in the superior vena 
cava via the jugular or subclavian vein is impossible, the alternative central venous access is 
the femoral vein. Unfortunately, monitoring ScvO2 is then out of the question. However, as 
shown in a recent survey, femoral venous oxygen saturation (SfvO2) is used during the first 
hours of treatment [14]. Femoral access is quick and relatively safe and potentially very 
useful in the care of acutely ill patients, especially if SfvO2 would provide diagnostic 
information in accordance with ScvO2. The question whether SfvO2 is such an attractive 
alternative is addressed in chapter 4. In 3 different populations the statistical agreement is 
described: stable cardiac outpatients, patients undergoing high-risk surgery, and critically ill 
ICU patients. 
Venous oxygen saturations are the best surrogates for global tissue hypoxia at this 
point and when used appropriately they are both useful diagnostic tools and of prognostic 
value. However, venous oxygen saturations do not have the exclusive right to these 
entitlements, because lactate has to be considered too. This product of metabolism, i.e. 
glycolysis, has been monitored in ICUs for many years. It is known that in anaerobic 
conditions lactate concentrations increases. As a consequence hyperlactataemia may serve 
as a marker for tissue hypoxia as well. But the pathophysiology of hyperlactataemia is 
complex and the meaning of hyperlactataemia in critically ill patients remains under debate 
[15,16]. This controversy includes the use of lactate as a marker of hypoxia [17]. 
Nevertheless, the prognostic value of lactate in this context has not been questioned as 
extensively.  
Clinical application of point-of-care measurements of arterial blood gas, glucose and 
lactate has been spread over the years in the emergency department (ED), operating room 
(OR) and ICU. With the introduction of hand held lactate metres it became possible to 
measure lactate outside these facilities or even outside the hospital. In chapter 5, the results 
are reported of a feasibility study on the use of such hand held metres in a prehospital 
setting. We compared the prognostic value of lactate with the prognostic value of vital signs 
in both shock and non-shock patients. This is relevant because if lactate would outperform 
vital signs, in non-shock patients especially, then lactate could be added to the current 
diagnostic pallet available to paramedics. 
In a later stage, i.e. after ICU admittance, persistence of hyperlactataemia could be a 
sign of on-going disease without apparent improvement. Hyperlactataemia is associated with 
multiple organ dysfunction syndrome (MODS) [18-21], which in turn influences the outcome 
of the septic patient [10]. Additionally, persistence of lactate levels above normal is 
associated with higher mortality rates in patients with severe sepsis or septic shock 
[20,22,23]. Therefore, it is possible that duration of hyperlactataemia  outperforms single 
lactate measurements in predicting outcome. In chapter 6 the relationship between 
hyperlactataemia  and organ failure as described by the Sequential Organ Failure 
Assessment (SOFA) is described in an ICU population of 2251 patients [24-26], in particular 
in relation to final outcome. 
Both ScvO2 and lactate are, to a greater or lesser extent, a reflection of a possible 
oxygen debt in critically ill patients. Above that, both values have been used in a diagnostic 
and therapeutic manner. However, normal values do not guarantee adequate tissue 
oxygenation and other circulatory parameters are needed to evaluate either treatment with 
catecholamines or resuscitation efforts altogether. One parameter that has been described in 
this context is the central venous-to-arterial carbon dioxide difference (pCO2 gap) [27]. The 
pCO2 gap reflects adequacy of blood flow [28,29], i.e. cardiac output (CO). CO, combined 
with other variables such as vital signs and ScvO2, gives us an idea on cardiac performance 
and physiological reserve of the patient. Hence, the pCO2 gap may be of additional value 
during resuscitation of critically ill patients. The final chapter of this thesis explores the place 
of the pCO2 gap in the resuscitation of patients with severe sepsis or septic shock during the 
first 24 hours after ICU admittance. 
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 Shock is defined as global tissue hypoxia secondary to an imbalance between 
systemic oxygen delivery and oxygen demand. Venous oxygen saturations represent this 
relationship between oxygen delivery and oxygen demand and can therefore be used as 
additional parameter to detect an impaired cardiorespiratory reserve. However, before 
appropriate use of venous oxygen saturations one should be aware of its physiology. This 
article describes the physiology of venous oxygen saturations and the use of both mixed 
venous oxygen saturation and central venous oxygen saturation in a variety of clinical 
settings.  
 Although venous oxygen saturation has been subject of research for many years, 
increasing interest arose especially in the last decade for its use as a therapeutic goal in 
critically ill patients and during the perioperative period. Also, there has been debate on 
differences between mixed and central venous oxygen saturation and their 
interchangeability. Both mixed and central venous oxygen saturation are clinically useful but 
both variables should be used with insightful knowledge and caution. In general, low values 
warn the clinician about cardiocirculatory or metabolic impairment and should urge for further 
diagnostics and appropriate action, whereas normal or high values do not rule out persistent 
tissue hypoxia. The use of venous oxygen saturations seems especially useful in the early 
phase of disease or injury. Whether venous oxygen saturations should be measured 
continuously remains unclear. Especially continuous measurement of central venous oxygen 
saturation as part of treatment protocol has shown to be a valuable strategy in the 
emergency department and in cardiac surgery. In clinical practice venous oxygen saturations 
should always be used in combination with vital signs and other relevant endpoints. 
Methods 
 We performed a search of the PUBMED database from 1980 to 2010 using 
combinations of the following terms: [SvO2, ScvO2, venous oxygen saturation, venous 
saturation, critically ill, shock, septic shock, high risk surgery, surgery, operation]. The articles 
published in English were included when published in a peer-reviewed journal. The clinical 
investigations had to concern adults. Additionally, bibliographies of relevant articles were 
screened as well. 
 
Physiology 
Understanding the physiology of venous saturations is essential for its effective 
application in critically ill patients and during the perioperative period. 
SvO2 depends on arterial oxygen saturation (SaO2), the balance between oxygen 
demand (VO2) and cardiac output (CO), and hemoglobin levels. According to the Fick 
principle [8], SvO2 can be described by the following formula: 
   SvO2  =  [SaO2  –   VO2 / CO ] [1 / Hb x 1,34] 
Increased VO2 will be compensated by increased CO. If this is not adequate, i.e. if O2 
demand is not met, elevated oxygen extraction in the peripheral tissues occurs and 
consequently SvO2 will drop. Thus, SvO2 reflects the balance between oxygen delivery and  
oxygen demand [9]. The normal range for SvO2 is 65 to 75% [4,10]. Low SvO2 is predictive of 
bad outcome [4,11], whereas normal or supra normal SvO2 (or ScvO2) values do not 
guarantee adequate tissue oxygenation [12,13]. If tissue is not capable of extracting oxygen, 
e.g. in case of shunting and cell death, venous return may have high oxygen content despite 
persistent cellular hypoxia. 
A variety of physiological and pathological changes may influence venous saturation 
(figure 1) and thus require different therapeutic interventions. Recognition of the aetiology of 




Figure 1. Multiple physiologic, pathologic and therapeutic factors may influence the value 
of central venous oxygen saturation. 
 
Central versus mixed venous oxygen saturation (table 1) 
In general there has been considerable debate on equality or interchangeability of 
ScvO2 and SvO2 [14-16]. In critically ill patients substituting SvO2 by ScvO2 results in large 
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and oxygen extraction by brain and splanchnic tissue. In this situation, ScvO2 may provide 
the false impression of adequate body perfusion. Also, whether a positive ScvO2 – SvO2 
gradient can be used as a marker of greater O2 utilization and predictor of survival remains 
subject of debate [20,22,23]. 
In contrast, others have stated that ScvO2 could indeed be used as a substitute for 
SvO2 [24-26]. For example, Reinhart et al. [24] performed continuous measurements of 
venous oxygen saturations in anesthetized dogs over a wide range of hemodynamic 
conditions, including hypoxia, haemorrhage and resuscitation, and described close tracking 
between ScvO2 and SvO2 [24]. However, correlation was lowest during hypoxia, one of the 
areas of greatest clinical interest. Nevertheless, precise determination of absolute values for 
SvO2 from ScvO2 was not possible, as was seen before [21,27-29]. 
 Additionally, the relationship between cardiac output (CO) or cardiac index (CI) and 
venous saturations has been evaluated in critically ill patients. So far, for both SvO2 and 
ScvO2 the results were inconclusive. Larger trials are needed before clinical 
recommendations can be made regarding their clinical use [19,30-33]. 
  
Table 1. Studies comparing mixed venous oxygen saturation and central venous oxygen saturation 
study design and subjects results conclusions 
 
Varpula et al [14] n=16; septic shock; ICU 
72 paired samples 
mean SvO2 below mean ScvO2 at all time points; 
 bias of difference 4.2%; 
95% limits of agreement -8.1 to 16.5%; 
difference correlated with CI and DO2 
difference between ScvO2 and SvO2 varied highly; 




Martin et al [16] n=7; 580 comparative measurements; 
critically ill patients; ICU 
with and without interventions 
 
difference were equal or greater than 5%  
in 49% during periods of stability and 
in 50% during periods with interventions 
ScvO2 monitoring not reliable 
Chawla et al [17] n=32 postsurgical, n=21 medical; 
ICU 
SvO2 consistently lower than ScvO2; 
mean (±SD) bias -5.2 ± 5.1% 
SvO2 and ScvO2 not equivalent; substitution of ScvO2 
for SvO2 in calculation of VO2 resulted in  
unacceptably large errors 
 
Kopterides et al [18] n=37; septic shock mean SvO2 below mean ScvO2;  
mean bias -8.5%; 
95% limits of agreement -20.2 to 3.3% 
 
ScvO2 and SvO2 not equivalent in septic shock; 
calculation of VO2 resulted in unacceptably  
large errors 
Ho et al [19] n=20; cardiogenic or septic shock ScvO2 overestimated SvO2 with mean bias 6.9%; 
95% limits of agreement -5.0 to 18.8%; 
changes did not follow the line of perfect agreement 
 
ScvO2 and SvO2 are not interchangeable numerically 
van Beest et al [20] n=53; 265 paired samples;  
sepsis; ICU 
multi centre 
mean SvO2 below mean ScvO2 at all time points;  
bias of difference 1.7% 
95% limits of agreement -12.1 to 15.5%;  
identical results for change in ScvO2 and SvO2 
 
ScvO2  does not reliably predict SvO2 in sepsis 
trend of ScvO2 not superior in this context 
 
Scheinmann et al [21] n=24; critically ill cardiac patients; 
CCU 
ScvO2 > SvO2 in shock 
changes in ScvO2 reflect changes in SvO2 (r=0.90); 
ScvO2 from right atrium is similar to SvO2 (r=0.96) 
SvO2 consistently lower than ScvO2 
poor correlation in heart failure or shock 
changes in ScvO2 reflect changers in SvO2 
 
Dueck et al [25] n=70; 502 comparative sets; 
neurosurgery 
95% limits of agreement 6.8% to 9.3% for single values 
correlations between changes of SvO2 and ScvO2:  
r=0.755, p < 0.001 
 
numerical ScvO2 values not equivalent to SvO2 in 
varying hemodynamic conditions; trend of ScvO2 
may be substituted for the trend of SvO2 
Reinhart et al [26] n=32; critically ill patients; ICU 
continuous parallel measurements 
ScvO2 closely paralleled SvO2; 
ScvO2 averaged (±SD) 7±4% higher than SvO2 
ScvO2 changed in parallel in 90% when SvO2 changed > 5% 
 
continuous fiberoptic measurement of ScvO2 
potentially reliable tool to rapidly warn of acute 
change in the oxygen supply / demand ratio 
Ladakis et al [28] n=31 surgical and n=30 medical; 
critically ill patients; ICU 
significant difference between mean ScvO2 and SvO2 
r=0.945 for total population 
 
ScvO2 and SvO2 are closely related and  
interchangeable for initial evaluation 
Tahvanainen et al [29] n=42; critically ill patients; ICU 
ScvO2 as representative of real 
changes in pulmonary shunt 
 
correlation between PA blood samples and both  
superior vena cava and right atrial blood samples 
ScvO2 can replace SvO2; 
exact SvO2 value can only be measured from PA 
 
CCU, cardiac care unit; ScvO2, central venous oxygen saturation; SvO2, mixed venous oxygen saturation; ICU, intensive care unit; VO2, oxygen consumption; CI, 
cardiac index; DO2, oxygen delivery; PA, pulmonary artery. 
  
Clinical use of venous oxygen saturations (table 2) 
Cardiac failure 
Venous oxygen saturations have been shown to have diagnostic, prognostic, and 
therapeutic qualities in critically ill patients having an acute myocardial infarction. Mixed 
venous oxygen saturation was particularly reduced in patients with cardiogenic shock or left 
ventricular failure. Patients with cardiac failure are unable to increase cardiac output during 
periods of increased oxygen need. Changes in oxygen demand will therefore only be 
compensated by changes in oxygen extraction in the same direction and indicated by inverse 
changes in venous oxygen saturations. Consequently, a drop in venous oxygen saturations 
will be a marker of cardiac deterioration. Patients with low venous oxygen saturations in early 
disease stage may considered to be in shock [34,35]. Also, patients with sepsis and known 
decreased left ventricular function seem to benefit from early goal-directed therapy (EGDT) 
when treated for sepsis [36] according to the Surviving Sepsis Campaign guidelines [37]. 
Finally, in the setting of cardio pulmonary resuscitation (CPR) a ScvO2 of 72% is highly 
predictive of return of spontaneous circulation [38]. 
Trauma 
In the initial assessment of trauma patients an adequate judgement of possible blood 
loss is essential. Compared to conventional parameters venous oxygen saturations are 
superior in predicting blood loss [39,40]. Moreover, after major trauma with brain injury ScvO2 
values below 65% in the first 24 hours are associated with higher mortality (28-days 
mortality; 31.3% vs. 13.5%) and prolonged hospitalization (45 vs. 33 days) [41].  
  
Table 2. Studies describing central venous oxygen saturation in clinical settings 
study design and subjects results conclusions 
 
Rady et al [1] n=36; critically ill patients; ED additional therapy is needed after hemodynamic 
stabilization to normal blood pressure and heart rate 
 
ScvO2 and can be utilized to guide 
thearpy  
Pope et al [13] n=619 registries treated with EGDT 
observational study 
groups: ScvO2 < 70%, ScvO2 71-89%, ScvO2 > 90% 
multivariate analysis: initial high ScvO2 higher mortality 
 
also high ScvO2 values predictive for 
mortality 
Ander et al [35] controls n=17, high-lactate group 
n=22, low lactate group n=5; 
chronic congestive heart failure; 
ED 
ScvO2 lower in high lactate group than in low lactate group 
(32±12% vs. 51±13%) and control (60±6%); after treatment 
significant decrease of lactate and increase in ScvO2  
in the high lactate group compared to low lactate group 
 
once patients with decompensated  
end-stage congestive heart failure 
are identified, aggressive alternative 
management is needed 
Scalea et al [40] n=26, trauma patients with 
suggested blood loss 
despite stable vital signs 39% of the patients had ScvO2 <65%;  
these patients required more transfusions; 
superiority ScvO2 to predict blood loss  
 
ScvO2 reliable and sensitive method for  
detecting blood loss; 
it is a useful tool in the evaluation 
 
Di Filippo et al [41] n=121 brain injury after trauma; 
non-controlled study 
nonsurvivors showed higher lactate, lower ScvO2 values; 
patients with ScvO2 ≤65% showed higher 28-day mortality, 
ICU LOS and hospital LOS than patients with ScvO2 >65% 
 
ScvO2 <65% in first 24 hours in patients 
with major trauma is associated with  
prolonged LOS and higher mortality 
 
Pearse et al [65] n=118, major surgery after multivariate analysis lowest CI and lowest ScvO2 were 
associated with post-operative complications;  
optimal ScvO2 cut-off for morbidity prediction:64.4% 
oxygen consumption is also an important 
determinant of ScvO2; reductions in 
 ScvO2 independently associated with 
post-operative complications 
 
Rivers et al [73] n=263; RCT; EGDT vs. controls 
severe sepsis, septic shock; ED 
EGDT (goal: ScvO2 ≥ 70%) showed better survival  
(absolute 16%), lower lactate; more fluids,  
red cell transfusion and inotropics 
 
EGDT provides benefits to outcome 
Trzeciak [74] n=16 pre-EGDT 
n=22 EGDT 
 
less PAC utilization; more fluids and dobutamine used;  
similar costs 
EGDT endpoint can reliably be achieved 
Kortgen [75] n=30 controls; n=30 septic shock 
implementation procedure 
septic shock 
use of dobutamine, insulin, hydrocortisone and aPC 
increased; amount of fluids and packed bloods cells 
unaffected; mortality in lower after implementation 
 
implementation of sepsis bundle feasible 
survival benefit 
Jones [76] n=79 pre-intervention 
n=77 post-intervention 
ED 
controls: more renal failure at baseline 
greater crystalloid volume and vasopressor infusion 
mortality 18 vs. 27% 
 
mortality reduction 
Micek [78] n=60 before implementation  
n=60 after implementation 
ED 
more appropriate antimicrobial regimen 
more fluids, more vasopressors 
less vasopressor by time of transfer to ICU 
 
shorter hospital LOS  
lower 28-day mortality 
Shapiro [80] n=51 historical controls 
n=79 septic shock 
patients received more fluids, earlier antibiotics, 
more vasopressors, tighter glucose control; 
not more packed blood cells 
 
implementation sepsis protocol feasible 
no survival benefit 
Jones et al [94] multicentre, randomized; n=300 
severe sepsis, septic shock 
goals: lactate clearance vs. ScvO2 
 
higher in hospital mortality ScvO2;  
no significant difference (predefined -10% threshold) 
no significant different mortality 
between normalization of lactate 
clearance compared to normalization 
ScvO2 
ED, emergency department; ScvO2, central venous oxygen saturation; EDGT, early goal-directed therapy; RCT, randomized controlled trial; ICU LOS, length of stay in 
intensive care unit; hospital LOS, length of stay in hospital; CI, cardiac index; SAPS II, simplified acute physiology score; ICU, intensive care unit. 
High-risk surgery 
In cardiac surgery patients, SvO2 has been shown to be superior to mean arterial 
pressure (MAP) and heart rate as qualitative warning sign of substantial hemodynamic 
deterioration. However, results on predictive value of SvO2 for CO in clinical settings are 
inconsistent [42-44]. Nevertheless, continuous SvO2 monitoring enables the early diagnosis 
of occult bleeding or could show poor tolerance of a moderate anaemia due to the inability of 
the patient with chronic heart dysfunction or preoperative negative inotropic treatment (e.g. 
beta-blockers) to increase CO in the face of anaemia. Furthermore, temporary decreases of 
SvO2 values after cardiac surgery are of prognostic value and may predict the development 
of arrhythmias [45-47]. Also, probably due to increased oxygen extraction ratio (O2ER) 
decreased SvO2 values during weaning from mechanical ventilation are predictive for 
extubation failure [48-50]. Finally, good predictive values of SvO2 for mortality have been 
described [51,52]. This suggests beneficial effects of SvO2 monitoring, at least during and 
after cardiac surgery. 
Goal Directed Therapy (GDT) has been shown to improve outcome after major 
general surgery [53] Originally, the goals in the protocol group were supra-normal 
hemodynamic and oxygen transport values (CI > 4.5 L/min/m2, DO2 > 600 ml/min/m
2, VO2 > 
170 ml/min/m2). In this group a significant reduction of complications, hospital stay, duration 
of mechanical ventilation and mortality was achieved when the PAC was placed 
preoperatively [54]. However, such strict predefined concept holds certain risks and should 
not be translated to all patients [55-57]. Meta-analyses of hemodynamic optimization in high 
risk patients revealed hemodynamic optimization to be beneficial only when interventions 
were commenced before development of organ failure [58,59]. Several of the studies 
described showed improved outcome, possibly including long-term survival, when GDT was 
commenced before surgery [54,60-62]. Maybe due to methodological shortcomings, a multi-
centre trial that randomised surgical patients to PAC guided or conventional management 
failed to show a difference in outcome [63,64]. More recently a reduction in post-operative 
complications and duration of hospital stay was described when GDT was used post-
operatively [65-67]. However, the abovementioned findings do not provide definite answers 
on how to use venous saturations as a therapeutic goal. Only one interventional trial used 
ScvO2 as a therapeutic goal in perioperative care [68]. After achieving predefined goals for 
arterial pressure, urine output, and central venous pressure, the intervention group received 
therapy to achieve the additional goal of an estimated oxygen extraction ratio < 27%. Fewer 
patients developed organ failure in the ScvO2 group [68]. 
. 
Sepsis and septic shock 
In a large multi-centre study 3 different cohorts of a very heterogeneous population of 
critically ill patients were compared for survival after different strategies for hemodynamic 
therapy had been applied: control vs. supra-normal values for the cardiac index (> 
4.5L/min/m2) or normal values for mixed venous saturation. In total, the anticipated goal was 
only achieved in one third of the patients. There was no significant reduction in morbidity or 
mortality in any group [69]. An important reason for this may be the late timing of the 
intervention, i.e. after occurrence of organ failure, implying that all patients suffered severe 
damage and received significant treatment before inclusion. 
Global tissue hypoxia as a result from systemic inflammatory response or circulatory 
failure is an important indicator of shock preceding multiple organ dysfunction syndrome 
(MODS). The development of MODS predicts outcome of the septic patient [37]. Treatment 
strategies aimed at restoring the balance between DO2 and VO2 by maximizing DO2 have not 
been successful [57,69,70]. 
 In line with studies over several decades [1,21,27,35,40,71] and based on 
recommendations [72] Rivers et al. randomized 263 patients with severe sepsis or septic 
shock to standard therapy or EGDT. Compared with the conventionally treated group, the 
ScvO2 guided group received more fluids, more frequently dobutamine, and more blood 
transfusion during the first 6 hours. This resulted in an absolute reduction in 28-day mortality 
of 16% [73]. 
A large amount of studies that implemented certain treatment protocols at the 
emergency department, including antibiotic therapy and tight glucose control for example, 
[74-79] showed significant decrease in mortality. EGDT endpoints (CVP 8-12 mmHg, MAP ≥ 
65 mmHg, and ScvO2 ≥ 70%) can well be achieved in an ED setting suggesting that a 
multifactor approach is a useful strategy in the treatment of sepsis [74-80]. Of note, three of 
these studies described similar populations with high percentage end-stage renal disease in 
the control group being prone for higher mortality [76,77,79,81]. Although attainment of an 
ScvO2 >70% has been reported as prominent factor for survival [82] several studies in which 
EGDT without that specific target was used were able to achieve a survival benefit as well 
[83-85]. In summary, as shown by Nguyen et al [86], the use of (modified) EGDT implies 
early recognition of the critically ill patient and enforces continuous reassessment of 
treatment. This seems to be the greatest gain in the treatment of patients with severe sepsis 
or septic shock over the last decade. 
Earlier studies that enrolled patients admitted at the intensive care unit (ICU) were 
unable to show a decrease in mortality after aggressive hemodynamic optimization [57,69]. 
In contrast, more recent studies that used modified EGDT protocols were able to show an 
significant decrease in mortality [85,87,88], suggesting that compliance to dedicated sepsis 
bundles after the ED stage can still be useful. 
However, low incidences of low ScvO2 values at ICU admission [89] or emergency 
department (ED) presentation [90] do occur together with baseline mortality compared to the 
original EGDT study [73,89,90]. For clinical appreciation of the abovementioned results a 
thorough look into the data is needed. Interestingly, in the EGDT study [73] less patients 
were intubated before first ScvO2 sampling and this could partially explain the difference of 
initial ScvO2 values between both studies [73,89]: due to higher DO2 (pre-oxygenation) and 
lower VO2 (sedation, paralysis; lower work of breathing) ScvO2 may very well improve in 
response to emergency intubation in the majority of patients [91]. This partially explaines the 
differences between populations [73,89,90] and provides another piece in the puzzle on the 
value of ScvO2 [93]. Nevertheless, applicability of the results of the EGDT trial may be 
dependent on geographical setting and underlying health care system [92,93]. 
Additionally, no difference in outcome was found between a resuscitation protocol 
based on lactate clearance and a ScvO2 based protocol [94] and ScvO2 optimization does 
not always exclude a decrease in lactate levels [95]. Also, the pursuit of ScvO2 values >70% 
does not always seem to be the optimal solution. Recent data suggest that also patients with 
initially high ScvO2 values may have adverse outcomes [12,13], probably due to impaired 
oxygen utilization. High ScvO2 values may thus represent an inability of the cells to extract 
oxygen or microcirculatory shunting in sepsis [96]. 
Finally, as a reflection of increased respiratory muscles O2ER a reduced ScvO2 or 
SvO2 predicts extubation failure in difficult-to-wean patients [48,97]. However, a successful 
intervention to increase ScvO2 in this context is not known yet. Nevertheless, it is 
conceivable that in the future ScvO2 will be used as a parameter in weaning protocols for a 
subset of patients [97,98]. 
 
Continuous measurement 
 Should continuous measurement be considered when venous saturations are used 
as a therapeutic goal? It may be argued that changes in venous saturations may occur 
rapidly, particularly in hemodynamically instable patients, and that discontinuous spot 
measurements by drawing intermittent blood samples may miss these changes. Accordingly, 
continuous measurement of SvO2 in septic shock patients revealed a higher frequency of 
short-term changes in SvO2 in nonsurvivors. Thus, variations in SvO2 could be of prognostic 
importance [99]. However, lack of therapeutic guidelines and cost effectiveness issues 
[5,7,58] question the clinical use of continuous measurement of SvO2 in critically ill. 
Continuous measurement in perioperative care allows detection of fluctuations. Low SvO2 
values have been associated with increased complications and morbidity, especially in 
cardiac surgery [100] and myocardial infarction and use of a SvO2>70% as a target seemed 
promising [38,43]. 
 There are currently two commercially available devices to measure ScvO2 
continuously. Continuous ScvO2 measurement as part of treatment protocol has shown to be 
a valuable strategy in the ED [71,73] and in cardiac surgery [101]. Additionally, Reinhart et al. 
concluded that continuous ScvO2 measurement in the ICU setting is potentially reliable [26]. 




 The on-going debate on differences between SvO2 and ScvO2 and their 
interchangeability should focus on well defined populations. Both SvO2 and ScvO2 are 
clinically useful but both variables should be used with knowledge and caution. Evaluating 
the available evidence in a clinical setting, we conclude that low venous oxygen saturations 
are an important warning sign of the inadequacy of systemic oxygen delivery to meet oxygen 
demands. Low values may warn the clinician about cardiocirculatory or metabolic impairment 
and should urge for further diagnostics and appropriate action, whereas normal or high 
values do not rule out persistent tissue hypoxia. Based on the numerous clues for its 
usefulness referred in this article the use of venous oxygen saturations seems especially 
useful in the early phase of disease or injury. In clinical practice venous oxygen saturations 
should always be used in combination with vital signs and other relevant endpoints.  
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Introduction Low mixed or central venous saturation (S(c)vO2) can reveal global tissue 
hypoxia and therefore can predict poor prognosis in critically ill patients. Early goal directed 
therapy (EGDT), aiming at a ScvO2 ≥ 70%, has been shown to be a valuable strategy in 
patients with sepsis or septic shock and is incorporated in the Surviving Sepsis Campaign 
guidelines. 
 
Methods We determined central venous pressure (CVP), hematocrit, pH, lactate and ScvO2 
or SvO2 in a heterogeneous group of critically ill patients early after admission to the 
intensive care units (ICUs) in 3 Dutch hospitals.  
 
Study design Prospective observational multicenter study. 
 
Results Data of 340 acutely admitted critically ill patients were collected. The mean SvO2-
value was > 65% and the mean ScvO2 was >70%. With mean CVP of 10.3 ± 5.5 mmHg, 
lactate plasma levels of 3.6 ± 3.6 and APACHE II-scores of 21.5 ± 8.3, the in-hospital 
mortality of the total heterogeneous population was 32.0%. A subgroup of septic patients (n = 
125) showed a CVP of 9.8 ± 5.4 mmHg, mean ScvO2 values of 74.0 ± 10.2% - where only 
1% in this subgroup revealed a ScvO2-value < 50% - and lactate plasma levels of 2.7 ± 2.2 
mmol/L with APACHE II-scores 20.9 ± 7.3. Hospital mortality of this subgroup was 26%. 
 
Conclusion The incidence of low ScvO2 values on acutely admitted critically ill patients is 
low in Dutch ICUs. This is especially true for patients with sepsis / septic shock. 
 Introduction 
Global tissue hypoxia as a result from systemic inflammatory response or circulatory 
failure is an important indicator of shock preceding multiple organ dysfunction syndrome 
(MODS). The development of MODS predicts outcome of the septic patient [1]. 
Unrecognized and untreated global tissue hypoxia increases morbidity and mortality. 
Accurate detection of global tissue hypoxia is therefore of vital importance. Physical findings, 
vital signs, measuring central venous pressure (CVP) and urinary output are of the utmost 
importance, but not always sufficient for accurate detection of global tissue hypoxia [2,3]. 
It is now generally accepted that a decreased central venous saturation (ScvO2) 
obtained from a central venous catheter, can reveal a mismatch between oxygen supply and 
oxygen demand, hence global tissue hypoxia [1]. Decreased values predict poor prognosis 
after cardiovascular surgery [4], in severe cardiopulmonary disease [5], and in septic or 
cardiogenic shock [6,7]. ScvO2 and SvO2 (mixed venous oxygen saturation) therefore can be 
used as hemodynamic goals during resuscitation. According to Rivers et al. [8] hemodynamic 
optimization demands ‘early goal-directed therapy’ (EGDT), including ScvO2-guided 
treatment. It was concluded that goal-oriented manipulation of cardiac preload, afterload and 
contractility, to achieve a balance between systemic oxygen delivery and oxygen demand is 
a valuable strategy in patients with sepsis or septic shock during the resuscitation period in 
the emergency department (ED) [8]. More recently, as a result of this study, an EGDT 
treatment protocol was included in the ‘Surviving Sepsis Campaign’ guidelines [1]. Also, 
several studies on implementation of such a protocol, partially in combination with other 
recommendations, have been published over the last years [9-11]. 
Based on clinical experience it seemed that the syndrome targeted in the EGDT study 
[8], was not very common in our ICUs and thus EGDT not being commonly indicated. Main 
purpose of this study was to determine the incidence of low ScvO2 values in our geographical 
setting. We monitored a heterogeneous group of critically ill patients during unplanned 
admission in 3 Dutch multidisciplinary ICUs. Also, illustratively, we compared the subgroup of 
septic patients with the population of septic patients as described by Rivers et al [8], with 




We studied ICU populations in one academic ICU [Academic Medical Center (AMC) 
in Amsterdam, The Netherlands] and two nonacademic ICUs [Gelre Hospital (GH) location 
Lukas in Apeldoorn, The Netherlands; Medical Center Leeuwarden (MCL) in Leeuwarden, 
The Netherlands]. The AMC is a large teaching hospital where the ICU is a 28-bed “closed 
format” department in which medical/surgical patients, including cardiothoracic and 
neurosurgical patients, are being treated. The GH is an affiliated teaching hospital where the 
ICU is a 10-bed “closed format” department. The MCL is a large general teaching hospital in 
the north of The Netherlands, with a 14-bed “closed format” mixed medical / surgical ICU, 
including cardiothoracic patients. 
 
Patients and data collection 
Between January 2006 and March 2007 a total of 340 patients, all 18 years or older, 
with a clinical indication for a central venous catheter (CVC) [BD Medical Systems, 
Singapore], pulmonary artery catheter (PAC) [Edwards Lifesciences LLC, Irvine, CA, USA] or 
Continuous Cardiac Output (CCO) catheter [Arrow Deutschland GmbH, Erding, Germany] 
(which measures SvO2 continuously) were recruited. Indication for a central venous, PAC or 
CCO catheter was left to the discretion of the attending physician. The patients arrived at the 
ICU either directly from the ED, from the general ward, or after acute surgery with severe 
sepsis, septic shock or cardiogenic shock, respiratory failure, central nervous problems, and 
other acute conditions. In the EDs there was no standardized protocol for hemodynamic 
treatment of septic patients. Fluid resuscitation was mostly guided by blood pressure 
monitoring. Inotropes were given scarcely at our EDs. Intubation on the ED was also 
uncommon. In the operating theatres no ScvO2 / SvO2 measurements took place, nor any 
kind of goal directed therapy was implemented. All patients were treated according to 
standard practice for the ICU. Exclusion criteria were elective surgery and age < 18 years. 
Collecting data for observational study without informed consent was approved by the 
Medical Ethics Committees of all 3 hospitals. 
Measurements of systolic arterial pressure (SAP), mean arterial pressure (MAP) and 
central venous pressure (CVP) were recorded immediately after arrival at the ICU. 
Hematocrit (Hct), lactate plasma levels and pH were determined from the first obtained 
arterial blood sample at the ICU. 




The statistical package for the social sciences (SPSS 15.0.1 for Windows) was used 
for statistical analysis. All data were tested for normal distribution with the Kolmogorov-
Smirnov test before further statistical analysis. Differences between both populations were 
assessed using Student’s paired t-test (normally distributed data). Data were displayed as 




A heterogeneous population with a total of 340 critically ill patients was evaluated in 
the three participating ICUs (table 1). The patients arrived at the ICU either directly from the 
ED (n=135; 40%), from the general ward (n=126; 37%) or after acute surgery (n=79; 23%). 
To determine ScvO2 or SvO2, central venous or mixed venous oxygen saturation was 
measured as early as possible after insertion of a central venous catheter (n=263) or 
pulmonary artery / CCO catheter (n=77). The vast majority (93%) of the patients were 
enrolled within 6 hours after presentation in the ER. More than 99% of all the data was 
obtained within 2 hours after ICU admission. The numbers of measurements of central or 
mixed oxygen venous saturation were not normally distributed between the three ICUs. In all 
three hospitals the mean SvO2 was higher than 65% and mean ScvO2 was higher than 70%. 
Overall in-hospital mortality of our population was 32.0%. 
In 263 patients venous oxygen saturation was measured centrally (table 2). Mean 
ScvO2 was 72.0 ± 12.3%. Thirty-eight patients (14%) had a ScvO2 < 60%, and only 14 (5%) 
patients had a ScvO2 < 50%. While only 1 patient of the latter was in septic shock, in-hospital 
mortality of these 14 patients was 57% (8/14). 
 
Septic patients 
In patients with sepsis or septic shock (n = 150) central venous oxygen was 
measured in 125 patients and mixed venous oxygen saturation was measured in 25 patients. 
The in-hospital mortality of our septic patients was 27%. Seventy-three patients arrived at the 
ICU from the general ward (n=73; 49%). The mean ScvO2 value was normal: 74.0 ± 10.2%. 
Only eight (6%) patients had a ScvO2 < 60%, and 1 (1%) < 50% (table 2). 
 
Table 1. Distribution of clinical problems in the three ICUs 








Sepsis/septic shock 47 (51) 64 (46) 39 (36) 150 (44) 
Cardiac failure, 









Respiratory failure 7 (8) 13 (10) 12 (11) 32 (9) 
CNS 5 (5) 7 (5) 10 (9) 22 (7) 
Other 6 (6) 18 (13) 17 (12) 41 (12) 
 
Data are presented as numbers (percentage); CNS, central nervous system; MCL, Medical Center 
Leeuwarden; GH,Gelre Hospital; AMC, Amsterdam Medical Center. 
 
Comparison with the EGDT population [8] 
Compared to the Rivers study group our septic patients revealed a significantly higher 
ScvO2 (74.0 ± 10.2 vs 48.9 ± 12.3%; p < 0.01), lower lactate plasma levels (2.7 ± 2.2 vs. 7.3 
± 4.6 mmol/L; p < 0.01), and lower hematocrit (30.3 ± 6.9 vs. 34.7 ± 8.5%; p < 0.01). Eighty-
three percent (83%) needed endotracheal intubation versus 55% in the EGDT study. 
APACHE II-scores were equal (20.9 ± 7.0 vs. 20.9 ± 7.2; p = 1.0). The in-hospital mortality of 
this subgroup was 26% (table 2). 
Mixed venous oxygen saturation 
Measurement of mixed venous oxygen saturation took place in 77 patients. Mean 
SvO2 was 68.2 ± 11.8%. Mean lactate was 4.3 ± 4.2 mmol/l; arterial pH was 7.30 ± 0.11. 
With mean APACHE II scores of 21.8 ± 7.3 and mean SOFA scores of 9.3 ± 3.6, the in-
hospital mortality was 37% (table 3). 
Table 2. Demographic data, variables and outcome data. Comparisons of sepsis patients with 
EGDT-study [8] data 

























heart rate (beats/min) 107 ± 27 115 ± 26 115 ± 29 1.0 
CVP (mmHg) 9.8 ± 5.4 10.8 ± 4.9 5.7 ± 8.5 <0.01
*
 
MAP (mmHg) 58 ± 16 60 ± 13 75 ± 25 <0.01
*
 
ScvO2 (%) 72.0 ± 12.3 74.0 ± 10.2 48.9 ± 12.3 <0.01
*
 
lactate (mmol/l) 3.3 ± 3.3 2.7 ± 2.2 7.3 ± 4.6 <0.01
*
 
arterial pH 7.33 ± 0.12 7.35 ± 0.10 7.32 ± 0.18 0.42 
hematocrit (%) 31.0 ± 7.0 30.3 ± 6.9 34.7 ± 8.5 <0.01
*
 
APACHE II score 21.5 ± 8.5 20.9 ± 7.3 20.9 ± 7.2 1.0 
SOFA score 9.5 ± 3.6 9.6 ± 3.0   














 sepsis subgroup vs. EGDT study. 
*
 Statistically 
significant difference. CVP, central venous pressure; MAP, mean arterial pressure; ScvO2, central 
venous oxygen saturation. 
  
Of the 25 patients in whom mixed venous oxygen saturation was measured in the 
subgroup of septic patients, four (16%) patients showed a SvO2 value <60% on admission. 
One patient (4%) had a SvO2 <50%. In this relatively small subgroup mean Hct was 28.2 ± 
5.4%, mean MAP 61.0 ± 13.4 mmHg and mean CVP 13.7 ± 4.6 mmHg, while 80% (20/25 
patients) needed mechanical ventilation. Mean APACHE II score was 22.2 ± 5.4 and mean 
SOFA score10.3 ± 3.7. The in-hospital mortality of this subgroup was 28% (table 3). 
Table 3. Demographic data, variables and outcome data; mixed venous 
saturations 














heart rate (beats/min) 102 ± 21 102 ± 21 
CVP (mmHg) 13.0 ± 4.9 13.7 ± 4.6 
MAP (mmHg) 61 ± 15 61 ± 13 
SvO2 (%) 68.2 ± 11.8 72.1 ± 10.8 
lactate (mmol/l) 4.3 ± 4.2 3.3 ± 2.3 
arterial pH 7.30 ± 0.11 7.32 ± 0.08 
hematocrit (%) 29.9 ± 7.1 28.2 ± 5.4 
APACHE II score 21.7 ± 7.3 22.2 ± 5.4 
SOFA score 9.3 ± 3.6 10.3 ± 3.7 
in-hospital mortality (%) 37.0 28.0 
Data are presented as means ± SD. CVP, central venous pressure; MAP, mean 
arterial pressure; SvO2, mixed venous oxygen saturation. 
Discussion 
The main result of this present multicenter observational study is the low incidence of 
low ScvO2-values (<50%) in septic patients being only 1%. Secondary findings are the 
normal mean ScvO2 values and normal mean SvO2 values in critically ill patients, including 
patients with severe sepsis or septic shock, on admission in the three ICUs. 
Development to severe sepsis and septic shock involves several pathogenic 
changes, including global tissue hypoxia as a result of circulatory abnormalities [14]. 
Especially hemodynamic optimization as a therapeutic target has been studied over the last 
decade [2,8,9,15,16]. Based on promising results of earlier studies [2], Rivers et al. 
randomized patients with severe sepsis or septic shock to standard therapy or EGDT. The 
latter resulted in an absolute reduction in 28-day mortality of 16% [8]. Improvement of the 
balance between oxygen delivery (DO2) and oxygen demand (VO2) played an important role. 
Other studies however found no reduction of morbidity or mortality as a result of aggressive 
hemodynamic optimization, despite higher central venous oxygenation or lower lactate 
concentrations [15,16]. Studies that enrolled patients admitted at the ICU were unable to 
show decrease in mortality after aggressive hemodynamic optimization [16,17], in contrast to 
studies that implemented certain treatment protocols, including antibiotic therapy, at the 
emergency department [8,9,11]. In this ICU study we found mean ScvO2 and SvO2 values in 
the normal range. Similar figures are described previously in the later stage of sepsis and in 
ICU patients [18,19]. This is in concordance with the findings by Gattinoni et al.(67,3-69,7%) 
[15] and Bracht et al. (70%) [20]. 
ScvO2 is a surrogate for SvO2: a significant correlation between the two has been 
described21. Although it might still be debatable whether central venous and mixed venous 
oxygen saturation are equivalent or not [18,19,21], the clinical importance of both 
measurements seems not to be an issue. The Surviving Sepsis Campaign recognizes such 
in the resuscitation portion of its severe sepsis and septic shock bundle [1]. Our study design 
does not allow any statistical evaluation of ScvO2 compared to SvO2. 
APACHE II-scores were similar in comparison to the population described in the 
EGDT study [8]. This suggests equal mortality rate predictions. However, physiologic scores 
such as APACHE II are dependent on variables that reflect the progression or reversal of 
organ dysfunction. Treatment in the ED or operating theatre prior to ICU admission 
influences calculation of the physiologic scores. Consequently, the physiologic scores at our 
ICUs could partially be underestimated. The significantly higher lactate plasma levels in the 
EGDT study suggests a more severe tissue hypoperfusion in that group. However, it is the 
clearance rate that is associated with less organ failure and improved survival [22]. 
Unlike significantly lower mean arterial pressures, the higher CVP and the lower 
hematocrit suggest that the septic patients were less hypovolemic compared to the EGDT 
population. Relatively high mean blood pressure in the EGDT population suggests an earlier 
stage of sepsis with predominating vasoconstriction, or pre-existing hypertension. The higher 
CVP in the subgroup with septic patients (n = 125) is partially the result of high percentage of 
endotracheal intubation and thus increased intrathoracic pressure before measurement 
(83%). In the EGDT study less than 55% needed intubation at admission. 
As mentioned earlier, in the present study the patients were treated in the ED, or 
elsewhere, before admission at the ICU. This treatment was different from the treatment 
given in the EGDT study. Nevertheless, our patients received some fluid therapy. 
Transfusion of red blood cells in our EDs was based on clinical suspicion or evidence of 
severe blood loss and not on low hematocrit only. Also, a main principle of treatment is to 
improve oxygen delivery and this could contribute to higher ScvO2 values in the ICU 
population compared to the patients described in the EGDT study and other ED studies. 
Other interventions such as sedation and analgesia, most often to facilitate endotracheal 
intubation and ventilation might have been beneficial for the balance between oxygen 
delivery and oxygen demand. Also the trend of changing ScvO2- and other physiological 
values, influencing outcome [23,24], is not taken into account in our study. Of course, all 
these factors are important differences between ER populations and ICU populations, but are 
not predominating. We are aware that comparison between those populations is limited by 
the abovementioned differences. 
As a result from the study design, statements about cut-off S(c)vO2 values for 
outcome prediction [20,24] or impact on therapeutic intervention, are not possible. Also, we 
did not look at the use of vital signs as indicator of tissue oxygenation in comparison to mixed 
or central venous saturation. Lack of clear insight of treatment and time spent at the different 
EDs, operating theatres or wards is a limitation of our study as well. Nevertheless, since we 
also aimed at the usefulness of measuring ScvO2 or SvO2 on ICU admission, we think these 
factors are not pertinent to the results. For example, Bracht et al. [20] found no correlation 
between ScvO2 values and length of hospital stay before unplanned ICU admission. 
Comparing our sepsis population with the ED population described in the important 
study by Rivers [8] is purely ment to be illustrative. Obviously, as we described, there are 
differences between ED and ICU populations in general. But there are also, depending on 
geographical setting, important differences between populations and health care systems. 
And so, we subscribe to the view of Ho et al. [25] that the syndrome described in the EGDT 
trial may be relatively uncommon depending on geographical setting and health care system. 
However, this does not undermine the importance of early identification of patients at high 
risk for cardiovascular collapse. For example, in our study of the fourteen patients with a 
ScvO2 < 50% the in-hospital mortality was 57%.Finally, the in-hospital mortality in our study 
was 32.0% for the total population and 27.0 % for the patients with severe sepsis or septic 
shock. Again this reflects recent findings by others: Ho et al. (30.2%) [25] and Shapiro et al. 
(26.9%) [26]. 
In conclusion, the incidence of low ScvO2 values on acutely admitted critically ill 
patients is low in Dutch ICUs. This is especially true for patients with sepsis / septic shock. 
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Introduction We tested the hypothesis that central venous saturation (ScvO2) does not 
reliably predict mixed venous saturation (SvO2) in sepsis. Additionally we looked at the 
influence of the source (splanchnic or non-splanchnic) of sepsis on this relation. 
 
Methods We concurrently determined ScvO2 and SvO2 in a group of 53 patients with severe 
sepsis during the first 24 hours after admission to the intensive care units in 2 Dutch 
hospitals. We assessed correlation and agreement of ScvO2 and SvO2., Additionally, we 
compared the mean differences between ScvO2 and SvO2 of both splanchnic and non-
splanchnic group. 
 
Study Design Prospective observational two-center study. 
 
Results A total of 265 paired blood samples were obtained. ScvO2 overestimated SvO2 by 
less than 5% with wide limits of agreement. For changes in ScvO2 and SvO2 results were 
similar. The distribution of the difference (ScvO2 - SvO2) (< 0 or ≥ 0) was similar in survivors 
and nonsurvivors. The mean (ScvO2 - SvO2) in the splanchnic group was similar to the mean 
(ScvO2 - SvO2) in the non-splanchnic group (0.8 ± 3.9% vs. 2.5 ± 6.2 %; p = 0.30). Oxygen 
extraction ratio (O2ER; p=0.23) and its predictive value for outcome (p=0.20) was similar in 
both groups. 
 
Conclusions ScvO2 does not reliably predict SvO2 in patients with severe sepsis. The trend 
of ScvO2 is not superior to the absolute value in this context. A positive difference (ScvO2 - 
SvO2) is not associated with improved outcome. 
Introduction 
Global tissue hypoxia as a result of systemic inflammatory response or circulatory 
failure is an important indicator of serious illness preceding multiple organ failure. The 
development of organ failure predicts outcome of the septic patient [1]. Unrecognized and 
untreated global tissue hypoxia increases morbidity and mortality: decreased mixed venous 
saturation (SvO2) values predict poor prognosis in septic shock [2-4]. 
Controversy however remains: there is no clear evidence that guiding hemodynamic 
optimization by monitoring central venous saturation (ScvO2) or SvO2 is useful in all patients 
with sepsis or septic shock, especially in intensive care unit (ICU) setting. The controversy 
includes their interchangeability [5,6]. 
Also, in patients with a splanchnic cause of sepsis, ScvO2 may be normal, while the 
SvO2 may be decreased due to elevated metabolic demand. On the other hand, due to 
sepsis related vasodilatation, also in the digestive tract, leading to diminished oxygen 
consumption, mixed venous saturation may be normal [7]. This could mean that the 5% 
difference between ScvO2 and SvO2 is not as consistent in sepsis as postulated earlier [8,9]. 
Nevertheless, recently an association between a positive gradient O2 gradient (ScvO2 – SvO2 
≥ 0) and ICU survival in critically ill patients was described [10]. Therapy aimed at increasing 
this gradient is could mean improved survival. However, this demands measurement of both 
ScvO2 and SvO2. 
We tested the hypothesis that ScvO2 does not reliably predict SvO2 in sepsis, i.e. a 
consistent 5% difference between ScvO2 and SvO2 does not exist. We also looked at the 
possible relationship between a positive difference between ScvO2 and SvO2 (ScvO2 - SvO2) 
and ICU survival. In a secondary analysis we tested the hypothesis whether the relationship 




We studied ICU populations in two teaching hospitals. The Martini Hospital 
[Groningen, The Netherlands] (MH) where the ICU is a 14-bed “closed format” mixed medical 
/ surgical ICU department and The Medical Center Leeuwarden [Leeuwarden, The 
Netherlands] (MCL) where the ICU is a 16-bed “closed format” mixed medical / surgical ICU, 
including cardiothoracic patients. The study was approved by both Local Ethics Committees. 
Informed consent was obtained in all cases from the patient or from the patient’s legal 
representative. 
 
Patients and data collection 
This prospective observational study included patients, all 18 years or older, with 
sepsis or septic shock according to international criteria [11], between January and 
September 2009. Only patients were included in whom there was a clinical indication for 
additional hemodynamic monitoring using a pulmonary artery catheter (PAC) [Criticath SP 
5507H TD, Becton Dickinson, Singapore] or a Continuous Cardiac Output (CCO) catheter 
[Arrow Deutschland GmbH, Erding, Germany]. The catheter was inserted into an internal 
jugular vein or subclavian vein according to standard procedure. Position was confirmed by 
the presence of pulmonary artery pressure tracings and chest radiography. No complications 
other than transient arrhythmias were observed during the insertion of any catheter. Primary 
data, including hemodynamic parameters, were collected at 6-hour interval (T0, T1, T2, T3, 
T4) during the first 24 hours after acute ICU admission. Standard blood samples of 2 ml were 
drawn simultaneously from distal (pulmonary artery; PA) and proximal / side portal (superior 
caval vein; SCV) from PAC or CCO catheter. To avoid falsely high readings due to aspiration 
of pulmonary capillary blood, aspiration was done gently to avoid high negative pressure 
when blood samples were taken. We took blood from the proximal port of the catheter as 
representative of central venous blood [6,8,10]. We did not use any continuously measured 
values of the catheter itself in the cases where a CCO catheter was used. Only patients with 
a complete series of 5 paired measurements were finally included. Also, arterial blood 
samples were obtained, including serum lactate. All blood samples were analyzed by a co-
oximeter (Radiometer ABL800 flex, Copenhagen, Denmark). The Acute Physiology, Age and 




Analysis was done for the total population and for secondary analysis the population 
was divided into two groups: patients with splanchnic source of sepsis and patients with a 
non-splanchnic source of sepsis. We calculated a sample size of 200 paired samples to 
detect an absolute difference between ScvO2 and SvO2 in a two-sided test with a 0.05 type I 
error and a 95% probability in case of standard deviation of 10% [13,14]. Statistical tests 
were two-tailed and performed by the statistical package for the social sciences (SPSS 
16.0.1 for Windows, Chicago, IL, USA) or MedCalc software (version 11.2.1, Mariakerke, 
Belgium), the latter for comparing ROC curves. GraphPad software (Prism 5.0, La Jolla, CA, 
USA) was used for graphics. Measurements were not independent but clustered within each 
patient. All data were tested for normal distribution with the Kolmogorov-Smirnov test before 
further statistical analysis. Differences between both groups were assessed using Student’s 
t-test in case of normal distribution or χ2 test. For each time point, T0 toT4, (ScvO2 - SvO2) 
was calculated including the average difference per patient. The agreement between 
absolute values of ScvO2 and SvO2 and the agreement of the changes of these values were 
assessed by the mean bias and 95% limits of agreement (mean bias ± 1.96 x standard 
deviation) as described by Bland and Altman [15]. χ2 test was used to establish significance 
between the number of survivors and non-survivors. Spearman correlations for assessing 
possible factors affecting (ScvO2 - SvO2) were determined: at each time point (ScvO2 - SvO2) 
was compared to hemodynamic and perfusion variables. 
For secondary analysis we also calculated the mean (ScvO2 - SvO2) per group and 
they were compared using Student’s unpaired t-test. Additionally, the influence on outcome 
of O2ER was determined because (ScvO2 - SvO2) did correlate with O2ER in the secondary 
analysis. SvO2 and arterial oxygen saturation (SaO2) were used in the calculation of the 
systemic oxygen extraction ratio (O2ER). Receiver Operating Characteristic (ROC) curves 
were used for the assessment of sensitivity and specificity of O2ER in predicting in-hospital 




We enrolled 56 patients, of whom three patients were excluded due to lack of data 
(technical problems). We evaluated data from 53 patients with sepsis. Altogether 265 paired 
blood samples were obtained. Baseline characteristics and outcome of the total population 
and both groups are shown in table 1. Length of stay at the ICU (LOSICU) was 12 ± 10 days 
and length of stay at the hospital (LOSHOSP) was 25 ± 18 days. 
  
Table 1. Baseline characteristics and outcome 








age (yr) 66 ±12 66 ± 12 66 ± 13 0.46 
CVP (mmHg) 12 ± 6 11 ± 5 14 ± 6 0.06 
MAP (mmHg) 66± 10 65± 12 66 ± 9 0.65 
ScvO2 (%) 72.0 ± 10.0 73.7 ± 10.5 70.6 ± 9.6 0.29 
SvO2 (%) 71.8± 10.6 75.2± 9.9 68.6 ± 10.5  0.03* 
lactate (mmol/L) 3.5 ± 3.5 3.8± 3.8 3.5 ± 3.2 0.33 
arterial pH 7.30± 0.10 7.29 ± 0.10 7.29 ± 0.12 0.43 
hematocrit (%) 30.1± 5.7 30.2 ± 6.1 32.1 ± 5.7 0.59 
APACHE II 26.6 ± 7.6 25.3 ± 7.3 28.7 ± 7.8 0.24 
hospital mortality (%) 26.5 29.2 24.0 0.56 
Data are presented as means ± SD or as numbers. 
#
 splanchnic group vs. non-splanchnic group. 
CVP, central venous pressure; MAP, mean arterial pressure; ScvO2, central venous oxygen 
saturation; SvO2, mixed venous oxygen saturation; APACHE II, acute physiology, age and 
chronic health evaluation; * statistically significant difference 
 
The ScvO2 overestimated the SvO2 by a mean bias (or absolute difference) of 1.7% ± 
7.1% in the total population. The 95% limits of agreement were wide (-12.1% to 15.5%; 
Figure 1A). Figure 2 illustrates this: mean ScvO2 and mean SvO2 values are shown at each 
time point. Results at time point T=0 and at different time points were similar, including wide 
limits of agreement (data and plots not shown). Bias between changes of ScvO2 and SvO2 
was 0.6% ± 7.1% in the total population with 95% limits of agreement of -13.4% to 14.6%; 
Figure 1B. Results were similar at time point T=0 and at different time points, including wide 
limits of agreement (data and plots not shown). 






































Figure 1. Bland and Altman plot showing the agreement between A. ScvO2 
and SvO2 (bias 1.7, 95% limits of agreement from -12.1 to 15.5) and in B. 




























Figure 2. Mean SvO2 and ScvO2 values at different time points. ScvO2 is 
consistently higher than SvO2 without statistical difference (paired t-test; 
all p > 0.05). 
 
 
Differences between survivors and nonsurvivors 
As ScvO2 of 70% has been used as a target for guided therapy in septic patients [4], 
we evaluated the frequencies of ScvO2 values below 70% in both survivors and 
nonsurvivors. Of all ScvO2 measurements in survivors 15% fell below 70%, whereas in 
nonsurvivors 47% of all ScvO2 measurements fell below 70% (p < 0.01). 
Assuming a 5% difference between ScvO2 and SvO2 [1], we also evaluated the 
frequencies of SvO2 values below 65% in both survivors and nonsurvivors. Of all 
measurements in survivors 7% fell below 65%, whereas in nonsurvivors 27% of all SvO2 
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Figure 3. Number of paired measurements resulting in either a 
(ScvO2 – SvO2) ≥0 (black bars) or in a (ScvO2 – SvO2) <0 
(white bars). There was no significant different distribution of 
(ScvO2 – SvO2) between survivors and non-survivors. 
Figure 3 shows the number of paired measurements resulting in either a (ScvO2 - 
SvO2)≥0 or in a (ScvO2 - SvO2) <0. There was no significant different distribution of (ScvO2 - 
SvO2) between survivors and non-survivors in the total population (p=0.13), splanchnic group 
(p=0.23) or non-splanchnic group (p=0.13). 
 
Influence on difference between ScvO2 and SvO2 (ScvO2 – SvO2) 
The difference between ScvO2 and SvO2 was dependent on the level of ScvO2 when 
values of <60%, 60-70%, 70-80% and >80% were analyzed separately. The mean (ScvO2 - 
SvO2) were 8.9%, 1.0%, 2.4%, and 4.2%, respectively. Due to low incidence (4.9%) of low 
ScvO2 values (< 60%) we did not assess statistics on these differences. Assessment of 
Spearman correlation coefficients did not show any relation between cardiac output (CO), 
cardiac index (CI), dopamine (μg/kg/min), norepinephrine (μg/kg/min), mean arterial blood 
pressure, arterial saturation, hemoglobin, hematocrit, pH, or lactate levels and (ScvO2 - 
SvO2) (all p > 0.05). O2ER correlated significantly with (ScvO2 - SvO2) at all time points (all p 
< 0.01). 
 
Differences between groups 
Secondary analysis showed that twenty-five patients presented with splanchnic 
source of sepsis and 28 patients presented with a non-splanchnic source of sepsis. Thirty 
patients (15 splanchnic / 15 non-splanchnic) were enrolled in the MCL and 23 (10 splanchnic 
/ 13 non-splanchnic) patients were enrolled in the MH. 
The sources of sepsis in the non-splanchnic group were mainly pneumonia (n = 16; 
57%) and infection of the urogenital tract (n = 5; 18%). Other sources were meningitis, 
arthritis, epiglottitis, endocarditis, and infected soft tissue. 
 
At baseline, SvO2 (75.2 ± 9.9% vs. 68.6 ± 10.5%; p = 0.03) was different between 
groups. There was no significant difference between the mean (ScvO2 - SvO2) of both 
groups: splanchnic, 0.8 ± 3.9% vs. non-splanchnic, 2.5 ± 6.2 % (p = 0.30). 
Bias between ScvO2 and SvO2 was 0.7% ± 6.3% (95% limits of agreement of -11.7% 
to 13.1%) in the splanchnic group and 2.6% ± 7.5% (95% limits of agreement of -12.2% to 
17.4%) in the non-splanchnic group. Bias between changes in ScvO2 and SvO2 was 0.9% ± 
7.9% (95% limits of agreement of -14.5% to 16.3%) in the splanchnic group and 0.3% ± 6.5% 
(95% limits of agreement of -12.4% to 13.0%) in the non-splanchnic group; plots not shown. 
The difference between ScvO2 and SvO2 was dependent on the level of ScvO2 when 
values of <60%, 60-70%, 70-80% and >80% were analyzed separately. The mean (ScvO2 - 
SvO2) were 12.3%, 2.1%, 1.0%, 4.3% for the splanchnic group; 4.6%, 0.1%, 3.8%, and 4.7% 
for the non-splanchnic group. 
There was no significant different distribution of (ScvO2 - SvO2) between survivors 
and non-survivors in both the splanchnic group (p=0.23) and the non-splanchnic group 
(p=0.13); Figure 4. 
Oxygen extraction ratio (O2ER) 
 The O2ER in the splanchnic group was similar to the O2ER in the non-splanchnic 
group (0.23 ± 0.07 vs 0.24 ± 0.09; p=0.23). Figure 4 shows the ROC curves of O2ER for the 
splanchnic and non-splanchnic group. Optimal value of O2ER was 0.22 (sensitivity = 0.46, 
specificity = 0.87) for the non-splanchnic group and 0.31 (sensitivity = 0.85, specificity 0.40) 
for the splanchnic group. These curves represent the reliability of the O2ER as predictor of 
in-hospital mortality. Area under the curve (AUC) in the splanchnic group was not 




Figure 4. ROC curves of O2ER for the splanchnic 
and non-splanchnic group. AUC in the splanchnic 
group (A) was not significantly larger than AUC in 




We could confirm our hypothesis that ScvO2 does not reliably predict SvO2 in patients 
with severe sepsis: the agreement of ScvO2 and SvO2 was clinically not adequate. The 
difference between ScvO2 and SvO2 varied according to the level of ScvO2, being the 
greatest in low (<60%) and high ranges (>80%). In patients with severe sepsis or septic 
shock the difference between ScvO2 and SvO2 appears not to be a fixed one and does not 
seem to be predictive for in-hospital mortality. Finally, the difference between ScvO2 and 
SvO2 is independent of several hemodynamic variables, with exception of O2ER. 
 The bias was small with ScvO2 being consistently larger than SvO2. However, this 
consistent bias also implies a greater relative error for SvO2 values at lower ScvO2 values. 
Additionally, the wide limits of agreement between ScvO2 and SvO2 are unacceptably wide 
and independent of time point. The widely assumed 5% difference between ScvO2 and SvO2 
[1,8,9] seems not consistent in patients with severe sepsis or septic shock. A variety of 
factors influence the difference between both variables in patients with sepsis: mixing of the 
less saturated blood from the coronary sinus in the right atrium, sepsis related vasodilatation, 
heterogeneity of flow within and between organs, and decreased cerebral oxygen uptake 
during sedation. Based on the present study, the net effect of these factors seems 
unpredictable. Our results seem concordant with earlier findings [6,8,16]. The first study 
described a small heterogeneous group of patients with septic shock. ScvO2 was consistently 
higher than SvO2 and the limits of agreement were equally wide. Moreover, the difference 
between ScvO2 and SvO2 varied according to the level of ScvO2 and deviated in the extreme 
ranges (60% < ScvO2 > 80%) [6]. The lower range (venous saturations < 60%) is clinically of 
the greatest interest because the patients admitted with such low venous saturations are the 
ones who could possibly benefit from ScvO2 -guided therapy [4]. With the results of the 
present study in mind the clinician should be aware of the large variability between ScvO2 
and SvO2. Clinically important, this large variability was already present on admission (T=0). 
At this time point the first decisions are made on how to resuscitate and on what goals 
should be achieved. Such large uncertainty in estimating SvO2 by ScvO2 is unlikely to be 
suitable for protocol-guided resuscitation in which decreases in SvO2 or ScvO2 may trigger 
therapeutic interventions. Normalization of ScvO2 after resuscitation will not automatically 
imply normalization of SvO2. 
 If the individual values of ScvO2 and SvO2 do not agree could this be different for the 
trends of ScvO2 and SvO2? In anesthetized subjects who underwent elective neurosurgery 
measurement of oxygen saturations was performed in various hemodynamic conditions. It 
was concluded that for clinical purposes the trend of ScvO2 might be substituted for the trend 
of SvO2 [17]. In the present study however, we found wide limits of agreement between the 
change of ScvO2 and the change of SvO2 in critically patients. As for the absolute values of 
ScvO2 and SvO2, substitution of the change of ScvO2 for the change of SvO2 in patients with 
sepsis is therefore undesirable. This is in concordance with earlier findings in patients with 
cardiogenic or septic shock: changes in ScvO2 and SvO2 did not follow the line of perfect 
agreement and ScvO2 and SvO2 were not considered to be interchangeable [18]. 
Another issue is whether a ScvO2 of 70% as treatment goal in sepsis or septic shock 
after resuscitation may be considered useful. In a study by Reinhart et al. ScvO2 was 
measured continuously in critically ill patients for an average of 42 hours. More than 87% of 
the values in nonsurvivors and 95% of the values in survivors were above 70%. This 
difference was significant. Average time per patient below the cutoff value was twice as long 
in nonsurvivors [5]. In the present study ScvO2 values in nonsurvivors fell also more 
frequently below the cutoff value of 70% compared to survivors and SvO2 values below 65% 
were more frequently found in nonsurvivors compared to survivors. Our data suggest that 
after the first hours of resuscitation monitoring of venous oxygen saturations could still be 
clinically relevant. 
 More recently, Gutierrez et al. described an association between a positive (ScvO2 – 
SvO2), and ICU survival in critically ill patients. A significantly greater number of survivors 
had a (ScvO2 - SvO2) ≥0 compared to non-survivors. The difference between ScvO2 and 
SvO2 became increasingly positive in survivors from initial to final measurement. They 
suggested that this might be associated with clinical recovery, perhaps reflecting a greater 
rate of O2 utilization [10]. This is in concordance with findings in post-operative cardiac 
patients which described a similar trend [19]. Although we noted that (ScvO2 - SvO2) was 
more frequently positive in survivors, and O2ER correlated with (ScvO2 - SvO2) we found no 
significant difference in distribution of (ScvO2 - SvO2) between survivors and non-survivors. 
Our results could not confirm a greater rate of O2 utilization in survivors as suggested by 
Gutierrez et al [10]. However, it is possible that the number of measurements in our study 
was not sufficient enough to detect a difference in distribution of (ScvO2 - SvO2). 
Secondary analysis showed that the inconsistent difference between ScvO2 and SvO2 
is independent of sepsis origin. There was no significant difference between the mean 
(ScvO2 - SvO2) of both groups and the limits of agreement were wide for both the absolute 
values and for the changes in ScvO2 and SvO2. SvO2 values were higher in the splanchnic 
group compared to the non-splanchnic group for a certain ScvO2 value. This phenomenon 
could be explained by sepsis related vasodilatation in the digestive tract. Despite 
heterogeneity of flow within and between various organs in patients with splanchnic sepsis 
[20] this leads to diminished oxygen consumption which results in a relatively higher SvO2. 
Apparently, a normal SvO2 does not rule out the presence of limited oxygen consumption in 
the splanchnic region [7]. Moreover, we found no difference in O2ER between the splanchnic 
and non-splanchnic group. This suggests less oxygen utilization in the digestive tract than 
could be expected based on the assumption that in all septic patients the difference between 
ScvO2 and SvO2 equals 5%. 
 This study has limitations. First, all patients were sedated, mechanically ventilated, 
and none of them were in hemorrhagic shock. Our findings may not be generalized to 
patients less critically ill or those with hemorrhagic shock. Also, due to intubation ScvO2 
values could have been relatively high in relation to disease severity [21]. Second, we 
investigated ICU patients which could mean at a later stage of sepsis; timing of 
measurements was probably not all in the same stage of critical illness. Third, in this study 
ScvO2 and SvO2 values did not change between different time points as a result of a 
protocolled intervention: conclusions on independence of time point are of limited value. 
However, measurements took place within individual patients: each subject served as its own 
control. Finally, we used the proximal port of the used catheters as surrogate of ScvO2. 
Some ScvO2 measurements might have been influenced due to a more distal location in the 
right atrium which allows mixing of superior and inferior caval vein blood. Nevertheless, our 
results are consistent and in concordance with previous studies where a similar technique 
was used [6,8,10]. 
 
Conclusions 
We conclude that ScvO2 does not reliably predict SvO2 in patients with sepsis, 
independent of sepsis origin. Assuming a consistent 5% difference between ScvO2 and SvO2 
can lead to erroneous clinical decisions. The change of ScvO2 compared to the change of 
SvO2 is not more reliable than the exact numerical values in this context. Finally, a positive 
difference (ScvO2 - SvO2) is not associated with improved outcome in patients with sepsis. 
The abovementioned conclusions apply for sepsis originated from both splanchnic and non-
splanchnic origin. 
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Objective The purpose of our study was to determine if central venous oxygen saturation 
(ScvO2) and femoral venous oxygen saturation (SfvO2) can be used interchangeably during 
surgery and in critically ill patients. 
 
Methods We concurrently determined SfvO2 and ScvO2 in a group of 100 stable cardiac 
patients, which served as control group. Furthermore, we determined simultaneously SfvO2 
and ScvO2 in 30 surgical patients and in 30 critically ill patients and evaluated changes over 
time. Correlation and agreement of SfvO2 and ScvO2 were assessed, including the difference 
between SfvO2 and ScvO2. 
 
Results Despite significant correlation between obtained values of SfvO2 and ScvO2 (rs = 
0.55; p < 0.001), the limits of agreement (LOA) were wide in the control group (mean bias 
2.7% ± 7.9%; 95% LOA: -12.9 to 18.2%). In both the surgical and critically ill patients, LOA 
(mean bias of -1.9% ± 9.3%; 95% LOA: -20.0% to 16.3%, and mean bias of 4.6% ± 14.3%; 
95% LOA: -23.5% to 32.6%, respectively) were wide. Results for changes of SfvO2 and 
ScvO2 were similar. During initial treatment of critically ill patients, the difference between 
SfvO2 and ScvO2, including its range of variation diminished. 
 
Conclusion There is lack of agreement between SfvO2 and ScvO2 in both stable and 
unstable medical conditions. Thus, SfvO2 should not be used as surrogate for ScvO2. 
Introduction 
Shock is defined as global tissue hypoxia secondary to an imbalance between 
systemic oxygen delivery (DO2) and oxygen demand (VO2). Unrecognized and untreated 
global tissue hypoxia increases morbidity and mortality [1-3]. Measurement of mixed venous 
oxygen saturation (SvO2) from the pulmonary artery (PA), i.e. the downstream site of the 
circulation, has been advocated as an indirect index of tissue oxygenation [4]. Hence, SvO2 
reflects the balance between oxygen delivery and demand [5]. The normal range for SvO2 is 
65 to 75% [4,6] and low SvO2 is predictive of bad outcome [4,7]. However, PA catheterization 
is costly and obtaining the first SvO2 values may be relatively time consuming. As a result of 
these disadvantages and an international debate on the use of PA catheter [8-10] its use has 
become, justifiable or not [11], somewhat unpopular. 
Just as SvO2, the measurement of central venous oxygen saturation (ScvO2) has 
been described to detect global tissue hypoxia. Early goal-oriented manipulation of cardiac 
preload, afterload and contractility, to restore the balance between systemic oxygen delivery 
and oxygen demand has been shown to improve outcome [12]. Although there has been 
considerable debate on equality or interchangeability of ScvO2 and SvO2, ScvO2 has been 
used as a therapeutic goal in resuscitation protocols as a surrogate marker for SvO2 [13]. 
To monitor ScvO2, insertion of a central venous catheter in the superior vena cava via 
the jugular or subclavian vein is required. However, sometimes the femoral vein is the 
preferred (inexperienced hands) or only possible (trauma; previous attempts failed) site for 
access in acutely ill patients. As shown in a recent survey, femoral catheters are commonly 
used during the first hours of treatment of critically ill patients [14]. Apart from possible 
disadvantages compared to jugular or subclavian portal such as arterial puncture and 
thrombosis [15], the use of femoral catheters has several advantages. Femoral access is 
quick, relatively safe and radiographic control is not required [16] because there is no risk for 
pneumothorax. Hence, the femoral venous access can be very useful in the care of acutely ill 
patients. 
There is little information on the relevance of SfvO2 [14,17,18]. The purpose of our 
study is first to determine if ScvO2 and femoral venous oxygen saturation (SfvO2) can be 
used interchangeably in critically ill patients and in high-risk surgery and second, to evaluate 




This prospective, observational, controlled study was performed in a non-academic 
university affiliated teaching hospital in The Netherlands [Gelre Hospital location Lukas in 
Apeldoorn, The Netherlands]. The ICU is a 12-bed “closed format” department. Per year 
about 17,500 surgical procedures are performed in this hospital. The study was approved by 
the Local Ethics Committee. Written informed consent was obtained in all cases from the 
patient or from the patient’s legal representative. 
 
Patients and data collection 
 Three groups of patients were analyzed. First, 100 stable cardiac outpatients who 
underwent elective right heart catheterization in day care. This population served as control 
group. Second, 30 high-risk (ASA score > 2) patients who underwent elective intermediate / 
high-risk surgery (surgical patients). Third, 30 consecutive critically ill patients who were 
acutely admitted to the ICU either directly from the ED, from the general ward or after acute 
surgery with septic shock [19] or cardiogenic shock [20] (ICU patients). 
 
 All included patients were older than 18 years. Exclusion criteria were acute 
abdominal or thoracic aneurysm, pregnancy, lack of data (technical problems) or lack of 
written informed consent. 
 In the control group not only ScvO2 and SfvO2, but also SvO2 was determined. During 
the right heart catheterizations 3 samples (femoral vein, proximal inferior caval vein, 
pulmonary artery) were obtained after routine cannulation of the femoral vein. Correct 
position of the catheter was confirmed by real-time angiography. 
In the surgical patients samples were obtained simultaneously before start of the 
procedure, i.e. after induction but before application of sterile sheeting (T=0), and at the end 
of the procedure, i.e. after sterile sheeting was removed (T=1). In the ICU patients samples 
were simultaneously obtained in the first hour of resuscitation (T=0) as soon as the central 
venous line was in place, and 6 hours thereafter (T=1). Femoral blood samples were 
obtained by puncture. 
 In the surgical and ICU patients hemodynamic measurements as well as blood 
samples and arterial blood gas analyses were recorded. Also, the use of fluids, packed red 
blood cells and vasopressors were recorded. 
 Central venous catheters [Edwards Lifesciences LLC, Irvine, CA, USA; usable length 
16 cm.] were inserted into an internal jugular vein or subclavian vein according to standard 
procedure. Correct position in the superior caval vein was confirmed by the presence of 
central venous pressure tracings and chest radiography. No complications other than 
transient arrhythmias were observed during the insertion of any catheter. In case of the use 
of a pulmonary artery catheter (PAC) [Criticath SP 5507H TD, Becton Dickinson, Singapore] 
in the ICU, blood samples were drawn from the proximal port of the catheter as 
representative of central venous blood [21-23]. All blood samples were analyzed by a co-
oximeter (Radiometer ABL800 flex, Copenhagen, Denmark). The Acute Physiology, Age and 
Chronic Health Evaluation (APACHE) II-score was collected for ICU patients [24]. 
 Statistical analysis 
Statistical tests were two-tailed and performed by the statistical package for the social 
sciences (IBM SPSS 19 for Windows, Chicago, IL, USA). GraphPad software (Prism 5, 
version 5.02 for Windows, and StatMate 2.0, San Diego, CA, USA) was used for graphics. 
Measurements were not independent but clustered within each patient. All data were tested 
for normal distribution with the D’Agostino-Pearson omnibus normality test before further 
statistical analysis. T-test (paired) was used where appropriate. Non-parametric testing of 
continuous variables was performed using Mann-Whitney-U test or Wilcoxon’s paired rank-
sum test. Otherwise the Fisher’s exact test was used. For both time points (T=0 and T=1) in 
the surgical and ICU group, (SfvO2 - ScvO2) was calculated. 
Paired samples were compared by (Spearman, rs) correlation [25] and the agreement 
between absolute values of ScvO2 and SfvO2 and the agreement of the changes of these 
values were assessed by the mean bias and 95% limits of agreement (mean bias ± 1.96 x 
standard deviation (SD)) as described by Bland and Altman (BA analysis) [26]. Limits of 
agreement  (LOA) were considered acceptable if they were within 5%. Based on the findings 
in the control group (SD 7 to 10; r = 0.60) we determined that number of paired samples 
required for a 90% power in a two-sided test with a 0.05 type I error would be 30. Data are 





 In 100 patients (46 males, 54 females) who underwent elective right heart 
catheterization we obtained 100 paired blood samples. Median age was 73 [63 - 80] years. 
  SvO2 and ScvO2 correlated significantly (p < 0.001) with rs = 0.85. BA analysis 
revealed a bias (or absolute difference) of 0.5% ± 2.8% (95% LOA of -4.8 to 5.9%). 
 Median SfvO2 was lower than median SvO2 (66.3 [58.1 - 73.0]% vs. 68.9 [64.3 – 
72.6]%; p=0.03). According to BA analysis the mean bias between SvO2 and SfvO2 was 
2.1% ± 7.9%; 95% LOA -13.0 to 17.5%. Correlation between SvO2 and SfvO2 was significant 
(rs = 0.57; p < 0.001). 
 Results for median SfvO2 and median ScvO2 were very similar. Median SfvO2 was 
lower than ScvO2 (66.3 [58.1 - 73.0]% vs. 69.2 [64.9 - 73.2]%; p < 0.01) According to BA 
analysis the bias between ScvO2 and SfvO2 was 2.7% ± 7.9% 95% LOA were -12.9 to 18.2% 
(figure 1). Fifty-five percent of the paired SfvO2 and ScvO2 samples diverged by > 5%. 
Nevertheless, ScvO2 correlated with SfvO2 (rs = 0.55; p < 0.001). 



















Figure 1. Control Group. Bland and Altman plot showing the 
agreement between ScvO2 and SfvO2 (bias 2.7%, 95% LOA 
from -12.9% to 18.2%). 
 
Surgery group 
 Altogether 60 paired blood samples were obtained in 30 patients. Baseline 
characteristics are shown in table 1. Co-morbidities in this group of surgical patients: arterial 
hypertension (20), cardiac (atrial fibrillation, coronary artery disease) (12), diabetes mellitus 
(9), chronic obstructive pulmonary disease (6), neurological (6), other (21). 










75 [64 - 81] 
 




75 [67 - 82] 
gender (male / female) 15 / 15 19 / 11 0.43 15/11 
MAP (mmHg) 74 [66 - 81] 74 [63 - 90] 0.75 74 [61 - 90] 
heart rate 
(beats / minute) 
73 [62 - 87] 109 [96 - 131] < 0.001 107 [96 - 114] 
hematocrit (%) 30.0 [27.8 - 34.0] 33.5 [30.0 - 37.0] 0.05 32.0 [30.0 - 35.5] 
FiO2 0.45 [0.40 - 0.50] 0.60 [0.40 - 0.65] 0.10 0.58 [0.40 - 0.60]  
APACHE II  22 [17- 28]  24 [15 - 30] 
CVC 
(jugular / subclavian) 
29 / 1 14 / 16 <0.001 12 / 14 
ScvO2 (%) 81.0 [ 78.0 - 86.5] 77.0 [65.8 - 83.3] 0.02 78.0 [65.7 - 83.0] 
SfvO2 (%) 83.0 [ 78.0 - 88.0] 71.0 [58.8 - 82.0] < 0.001 74.0 [63.5 - 81.2] 
 
ICU, intensive care unit; MAP, mean arterial pressure; FiO2, fraction of inspired oxygen; APACHE II, acute 
physiology, age and chronic health evaluation; CVC, central venous catheter; ScvO2, central venous oxygen 
saturation; SfvO2, femoral venous oxygen saturation. Data are presented as median [IQR] or as numbers; P 
value, ICU vs. surgery. 
 Types of surgery (and number) performed on these patients were as follows: liver (9), 
lung (8), colon (6), aorta (4), and other (3). Median length of stay in the hospital (LOSHOSP) 
was 10 [6-19] days. Post-operative complications included: pneumonia (4), ileus (4), 
relaparotomy (4), cardiac ischemia (3), de novo atrial fibrillation (2), neurological (1), wound 
infection (1), urinary tract infection (1), systemic inflammatory response syndrome (1), 
pulmonary embolus (1), and other (5). None of the patients died postoperatively in the 
hospital. 
 At T=0 the SfvO2 underestimated the ScvO2 (bias of -1.9% ± 9.3%). The 95% LOA 
were -20.0% to 16.3% (figure 2). At T=1 the SfvO2 underestimated the ScvO2 (bias of -1.0% 
± 14.9%). The 95% LOA ranged from -30.2% to 28.3% (figure 2). At both time points SfvO2 
and ScvO2 did not correlate significantly (p = 0.23 and p = 0.06, respectively). The 
differences between median (SfvO2 - ScvO2) at T=0 and T=1 were not significant (2.0 [-5.0 - 
7.5]% vs. 4.0 [-6.5 - 7.0]%; p = 0.71). The median changes of SfvO2 and ScvO2 from T = 0 to 
T = 1 were equivalent (-5.0 [-13.8 - 5.8]% vs. -2.0 [-11.0 - 2.5]%; p = 0.89). In only 57% the 
changes in SfvO2 and ScvO2 over time were in the same direction; this was independent of 
the type of surgery. 
 
ICU group 
 Thirty acutely admitted patients were included. Baseline characteristics are shown in 
table 1. At admission, four patients were in cardiogenic shock based on acute coronary 
syndrome or cardiac failure. Twenty-six patients were in septic shock. Causes of sepsis were 
respiratory (n=13), abdominal (n=8), urological (n=2), or other (n=3). In the majority of 
patients (28/30) one or more inotropes were used (28/30): dopamine (n=1), norepinephrine 
(n=16), milrinone (n=26), isoprenaline (n=1). 
 
 Figure 2. Bland and Altman plots showing the agreement between ScvO2 and SfvO2 in the 
surgery group at T=0 and T=1 and in the ICU group at T=0 and T=1; various bias and 95% LOA 
in results section. 
 
 At T=0 the SfvO2 overestimated the ScvO2 (bias of 4.6% ± 14.3%). The 95% LOA 
were -23.5% to 32.6% (figure 2). At T=1 the SfvO2 overestimated the ScvO2 (bias of 3.3% ± 
11.1%). The 95% LOA ranged from -18.5% to 25.1% (figure 2). At both time points SfvO2 
and ScvO2 correlated significantly (p = 0.01 and p = 0.002, respectively) with comparable rs 
(0.46 vs. 0.55). The difference between SfvO2 and ScvO2 and the range of variation 
diminished over time (from -4.0 [range -44.0 to 28.0] at T=0 to -1.0 [range -32.0 to 11.0] at 


















Figure 3. ICU group. The median 
difference between SfvO2 and ScvO2 at 
T=0 (-4.0%, range -44% to 28%) and T=1 
(-1.0%, range -32% to 11%). 
 Changes of SfvO2 and ScvO2 over time occurred in the same direction in 87%  of the 
cases (26/30; in-hospital mortality 27% (7/26)). In twenty of these patients the value of both 
SfvO2 and ScvO2 increased; mortality of this subgroup was 25% (5/20). In four cases ScvO2 
increased after treatment while SfvO2 decreased. In-hospital mortality in this small subgroup 
(75% (3/4)) was not significantly higher compared to the other 26 patients (p=0.33). The 95% 
LOA between both changes were -32.6% to 30.1%. The total in-hospital mortality in this 
group was 33%. 
 Results for 26 patients in septic shock were similar to the results of the total ICU 
group (table 1). At T=0 the SfvO2 overestimated the ScvO2 (bias of 2.2% ± 12.8%). The 95% 
LOA were -27.5% to 22.8%. At T=1 the SfvO2 overestimated the ScvO2 (bias of 3.5% ± 
11.9%). The 95% LOA ranged from -26.5% to 19.9%. At both time points SfvO2 and ScvO2 
correlated significantly (p = 0.01 and p = 0.003, respectively) with comparable rs (0.43 vs. 
0.54). Median LOSHOSP was 13 [5-27] days and in-hospital mortality was 35% (9/26). 
 
Comparison between patient groups 
 Gender and age were equally distributed in the control and surgery group (table 2). 
The absolute values of SfvO2 and ScvO2 were higher in the surgery group compared to the 
control group (table 2). The difference between SfvO2 and ScvO2 values also varied 
significantly between study groups (table 2). 
 
Table 2. Comparison of study groups (T=0) 
 control 
















SfvO2 - ScvO2 (%) 
 
73 [63-80] 
46 / 54 
 
69.2 [64.9 - 73.2] 
66.3 [58.1 - 73.0] 
-1.5 [-8.5 - 2.7] 
 
75 [64 - 81] 
15 / 15 
 
81.0 [ 78.0 - 86.5] 
83.0 [ 78.0 - 88.0] 










19 / 11 
 
77.0 [65.8 - 83.3] 
71.0 [58.8 - 82.0] 








ICU, intensive care unit; m, male; f, female; ScvO2, central venous oxygen saturation; SfvO2, femoral venous 
oxygen saturation; SfvO2 - ScvO2, difference between SfvO2 and ScvO2; 
a
 surgery vs. control group; 
b
 ICU vs. 
control group; Data are presented as median [IQR] or as numbers. 
 In contrast to the median value of SfvO2 median value of ScvO2 was higher in the 
acutely admitted critically ill patients compared to the patients in the control group. 
 The absolute values of the venous oxygen saturations were significantly lower in the 
septic ICU patients (ScvO2 77.0 [65.8 - 83.3]%; SfvO2 71.0 [58.8 - 82.0]%) than in surgical 
patients (ScvO2 81.0 [78.0 - 86.5]%; SfvO2 83.0 [78.0 - 88.0]%) at T=0. This difference 
disappeared at T=1 (table 3). 






T = 0    
MAP (mmHg) 74 [66 - 81] 74 [63 - 90] 0.75 
heart rate (beats / minute) 73 [62 - 87] 109 [96 - 131] < 0.001 
ScvO2 (%) 81.0 [78.0 - 86.5] 77.0 [65.8 - 83.3] 0.02 
SfvO2 (%) 83.0 [78.0 - 88.0] 71.0 [58.8 - 82.0] < 0.001 
FiO2 0.45 [0.40 - 0.50] 0.60 [0.40 - 0.65] 0.10 
SfvO2 - ScvO2 2.0 [-5.0 - 7.5] -4.0 [-12.3 - 2.5] 0.03 
 
T = 1    
MAP (mmHg) 77 [72 - 94] 65 [59 - 74] < 0.001 
heart rate (beats / minute) 82 [66 - 99] 99 [84 - 109] 0.03 
ScvO2 (%) 79.0 [72.8 - 83.0] 81.5 [75.0 - 83.3] 0.47 
SfvO2 (%) 83.0 [71.5 - 87.0] 79.5 [72.0 - 85.0] 0.46 
FiO2 0.45 [0.40 - 0.67] 0.45 [0.40 - 0.60] 0.53 
SfvO2 - ScvO2 4.0 [-6.5 - 7.0] -1.0 [-6.8 - 4.3] 0.08 
 
change of ScvO2 (T1 – T0) -2.0 [-11.0 - 2.5] 5.0 [ 1.0 - 10.3] 0.001 
change of SfvO2 (T1 – T0) -5.0 [ -13.8 - 5.8] 4.5 [-4.8 - 21.0] 0.01 
total infusion (ml) 3150 [ 1534 - 4795] 3286 [2369 - 5135] 0.43 
fluid balance (ml) 272 [-525 - 1127] 2589 [1137 - 3721] 0.01 
ICU, intensive care unit; MAP, mean arterial pressure; FiO2, fraction of inspired oxygen; APACHE 
II, acute physiology, age and chronic health evaluation; CVC, central venous catheter; ScvO2, 
central venous oxygen saturation; SfvO2, femoral venous oxygen saturation. Data are presented as 
median [IQR] or as numbers. 
Discussion 
We conclude that SfvO2 should not be used as a surrogate of ScvO2 due to the lack 
of agreement between both variables under different circumstances. This uncertainty in 
estimating ScvO2 by SfvO2 hampers protocol-guided hemodynamic optimization in which 
decreases in SfvO2 of ScvO2 may trigger therapeutic interventions. As for the absolute values 
of SfvO2 and ScvO2, substituting the change of ScvO2 by the change of SfvO2 is not suitable. 
These results are of confirmative but also additional value with respect to recent reports on 
populations of critically ill patients [14, 17]. 
This is the first study describing the relationship between femoral and non-femoral 
central venous saturations in outpatients. Although those patients do not resemble healthy 
volunteers, the results will give us at least an idea of the physiological relationship between 
femoral and non-femoral central venous saturations in stable hemodynamic conditions. In 
these stable conditions without any reason for redistribution of blood flow, the median values 
of ScvO2 or SvO2 and SfvO2 were significantly different, and LOA as described by BA 
analysis were wide. Apparently, even in stable hemodynamic conditions a statement on the 
systemic balance between oxygen delivery and oxygen demand should not be based on 
SfvO2 values. 
 No study compared ScvO2 and SfvO2 in surgical patients before. In the present study 
mean biases between ScvO2 and SfvO2 were relatively small during anesthesia in 
intermediate and high-risk surgery but LOA were wide. The Bland and Altman projections 
implacably demonstrate that several values differed even more than 15% from each other. 
Even more concerning was the lack of predictability for the direction of change of ScvO2 by 
SfvO2: it’s like tossing a coin. We think that peri-operative protocols as suggested for ScvO2 
[27,28] should not be based on SfvO2 values. 
 
 Treatment of shock implies improvement of the circulatory state with redistribution of 
flow not only in vital organs but also in more peripheral tissue, including limbs. The results in 
the ICU group elegantly show that after 6 hours of intensive treatment the mean difference 
between SfvO2 and ScvO2 decreased, i.e. after reversal of shock and improvement of the 
circulation SfvO2 approached ScvO2. In the vast majority of patients changes of SfvO2 and 
ScvO2 occurred in the same direction, i.e. rise or fall, during resuscitation. Although not 
significant due to insufficient power, the mortality rate was higher when ScvO2 increased but 
SfvO2 decreased after 6 hours of treatment in the ICU (3/4; 75%). Apparently, in these cases 
treatment failed to improve circulation and shock was not adequately reversed. Also, regional 
(splanchnic, leg blood flow) changes in oxygen delivery and consumption cannot predict 
systemic changes [28] and differences in regional oxygen extraction ratio [29] attribute to the 
differences between ScvO2 and SfvO2 in our study. In conclusion, SfvO2 did not adequately 
predict ScvO2 in critically ill patients. This is in line with recent clinical work in which a similar 
lack of agreement between SfvO2 and ScvO2 was described [14,17]. Both studies describe 
wide LOA as well, i.e. more than 50% of ScvO2 and SfvO2 values diverged by more than 5% 
[14,17]. Although in those studies more critically ill patients (n=39 and n=43, respectively) 
were included than in the present study, our study carries a control group and compares 
changes of both values over time. 
 Several strengths of this study should be mentioned. First, a relatively large group of 
stable cardiac patients served as control group. Second, a power analysis was performed 
before the start of the study. Third, we did not only compare absolute values but also 
changes over time of both ScvO2 and SfvO2 during treatment in surgery and in the ICU. 
Fourth, femoral blood samples were taken by puncture, which excludes possible influences 
of the catheter length on oxygen content or reliability of the samples. 
 
 However, this study also has limitations. First, measurements were done intermittently 
and not continuously. Second, all surgical and ICU patients were sedated, mechanically 
ventilated, and none of them were primarily in hemorrhagic shock. Therefore care must be 
taken before generalizing our results to other patients with different pathophysiology. Third, 
we investigated acutely admitted ICU patients and timing of measurements was probably not 
always in the same stage of disease. However, this approach reflects common clinical 
practice and is a well-known drawback in all studies involving critically ill patients. Fourth, 
one may argue that movements of the legs, especially during global hypoxia may have 
influenced the results. However, all cardiac patients were stable, locally anaesthetized and 
lying still during the procedure. All surgical and most (28 out of 30) ICU patients were 
measured after induction of general anesthesia. The other two ICU patients were quiescent 
at the time of measurements. Furthermore, the occurrence of strong leg movements would 
have caused even larger differences between ScvO2 and femoral venous saturations than 
reported in our results. Hence, we do not think this potential confounder plays a role in our 
study. Finally, in this study ScvO2 and SfvO2 values did not change between different time 
points as a result of a study intervention. However, measurements took place within 
individual patients: each subject served as its own control. 
 
Conclusion 
SfvO2 cannot replace ScvO2, neither in stable conditions nor during surgery or during the 
resuscitation phase in critically ill patients. 
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Objective We evaluated the relationship of lactate measured in a pre-clinical setting to 
outcome. Simultaneously, we evaluated the feasibility of implementing blood lactate 
measurement in a pre-hospital setting as part of a quality improvement project. 
 
Methods Chart review of patients from whom serum lactate levels prospectively were 
obtained in a pre-hospital setting. Total population was divided into two groups, i.e. a shock 
group and a non-shock group according to predefined shock symptoms. The shock group 
was divided into two groups, i.e. a lactate < 4mmol/L (subgroup I) and a lactate ≥ 4mmol/L 
(subgroup II). 
 
Results In about 50% of possible cases lactate was measured in the pre-hospital setting. 
Median lactate in subgroup I (n=74) was 3.2 (1.5-3.9) mmol/L vs. 5.0 (4.0-20.0) mmol / L in 
subgroup II (n=61) (p < 0.0001). Significant differences were found in length of stay in 
intensive care unit (p = 0.03) or hospital (p = 0.04) and mortality (subgroup I 12.2% vs. 
subgroup II 44.3%; p = 0.002). In normotensive shock patients revealing a lactate ≥ 4mmol/L 
(n=27) the mortality was higher compared to normotensive shock patients with a lactate < 
4mmol/L (n=31) (35% vs. 7%; p < 0.001). 
 
Conclusion Implementation of lactate measurement in pre-hospital setting is feasible, and 
potentially clinical relevant. Lactate measured in a pre-clinical setting is related to outcome. 
Subsequent studies should evaluate if treatment of shock patients based on pre-hospital 
lactate measurement will improve outcome. 
Introduction 
Physical findings and vital signs are important, but not always sufficient for accurate 
detection of global tissue hypoxia [1]. Global tissue hypoxia as a result from systemic 
inflammatory response or circulatory failure is an important indicator of shock preceding 
multiple organ dysfunction syndrome (MODS). Due to global tissue hypoxia, with 
concomitant risk of developing an oxygen debt, anaerobic metabolism occurs and lactate 
production is increased. If this situation persists, the lactate metabolic clearance rate is 
surpassed and circulating lactate levels may be elevated as well. 
Numerous studies have established the use of lactate as a diagnostic, therapeutic 
and prognostic marker in different shock states and other critical conditions [2-5]. Serum 
lactate concentrations > 4 mmol/L are unusual in normal and not critically ill hospitalized 
patients, independent of underlying comorbidities [6]. Lactate concentration > 4 mmol/L in the 
presence of systemic inflammatory response syndrome (SIRS) criteria significantly increases 
intensive care unit (ICU) admission rates and mortality rate in normotensive patients [7]. 
Also, lactate represents a useful and clinically obtainable surrogate marker of tissue hypoxia 
and disease severity, independent of blood pressure [8]. This was corroborated by others, 
who also demonstrated that early lactate clearance was associated with decreased mortality 
rate in patients with severe sepsis and post-cardiac arrest patients [9,10]. These findings 
have facilitated the clinical application of point-of-care measurements and portable 
monitoring of lactate over the past decade in the emergency department (ED), operating 
theatre and ICU [11-13]. In addition, several years ago Shapiro et al. suggested that lactate 
seemed a promising risk-stratification tool in the ED setting [14]. They found a significant 
higher mortality rate in patients with a serum lactate ≥ 4 mmol/L. Measurement of serum 
lactate in a pre-hospital setting, i.e. in the ambulance, could warn paramedics of pending 
organ failure despite normal global hemodynamic parameters. We evaluated the relationship 
of lactate measured in a pre clinical setting to outcome. Simultaneously, we evaluated the 
feasibility of implementing blood lactate measurement in a pre-hospital setting as part of a 




 We studied charts of ambulances that arrived at a non-academic medical centre 
[Gelre Hospital (GH), site Lukas, Apeldoorn, The Netherlands]. These charts are 
standardized by the Dutch ambulance organization. The GH is an affiliated 925-bed teaching 
hospital and the ICU is a 14-bed “closed format” department. The ambulance service covers 
an area of about 2000 km2 with approximately 620,000 inhabitants. The ambulance service is 




 From an environmental scan [15] we learned that in the Netherlands measurement of 
lactate has not been done in daily practice throughout the pre-hospital phase. Because 
lactate measurement was an unknown feature for our ambulance personnel the next phase 
of implementation, setting a target, seemed important to prepare them for a change in 
behaviour. To make behavioural change possible, teaching regarding why, what, and when 
for changing behaviour is crucial. During the two months prior to the first blood lactate 
measurements in pre-hospital setting all ambulance personnel was trained. First, as part of 
the education program, one of the investigators (PS) explained in a lecture the theoretical 
essence of this project. The why, the expected potential benefit for shock patients in the 
future was also mentioned. Finally, all ambulance personnel received a two hour course on 
working with the lactate meter (Accutrend© lactate meter (Roche Diagnostic GmbH) in the 
field. This course was not only theoretical but also contained actual practice. With this course 
we intended to lower the threshold in the field for the use of an extra device. The emphasis 
on who to change was focused on the ambulance personnel. 
 
Patients and data collection 
 This study is a chart review of patients from whom serum lactate levels prospectively 
were obtained in a pre-hospital setting. Total population was divided into two groups, i.e. a 
shock group and a non-shock group according to predefined shock symptoms which were 
defined as 1) a heart rate <50 or >100 beats per minute, 2) systolic blood pressure <90 
mmHg, 3) respiration rate <10 or >30 breaths per minute, 4) peripheral arterial oxygen 
saturation <95% (COPD patients <90%), 5) collapse or Glasgow Coma Scale (GCS) <14. 
Patients suffering from two or more of these symptoms were included in the shock group; 
those with none or one deviated shock parameter were included in the control (non-shock) 
group. Exclusion criteria were age <18 years, hypoglycemia, seizures, no consent, treatment 
not according to the Dutch national ambulance protocol (“Landelijk Protocol Ambulance”, 
LPA 7) or lacking data. In the field respiration rate was noted according to the Dutch national 
ambulance chart, being five options: none, 1-5, 6-9, 10-29 and more than 30 breaths per 
minute. For analysis, respiratory rates were divided into three categories: 0-9, 10-29 and >30 
breaths per minute [16]. After defining the non-shock and shock group the latter population 
was divided into two subgroups: one subgroup with blood lactate < 4 mmol/L (= subgroup I) 
and another subgroup with blood lactate ≥ 4 mmol/L (= subgroup II). Early treatment given in 
pre-hospital setting was divided in three categories: 1) oxygen plus basic peripheral IV line; 




 During the maintenance phase all lactate meters (Accutrend© lactate meter (Roche 
Diagnostic GmbH) were calibrated regularly according instructions by the manufacturer. 
Capillary or venous lactate levels were measured with these meters. Local coordinators were 
interviewed on the experiences of the ambulance personnel, the lactate meter and its use in 
the field. Also points for improvement were noted. 
 Vitals were determined with Lifepack© 12 (Medtronic). Collecting data was approved 
by the Medical Ethics Committee. Informed consent was obtained from all participants. 
 
Statistical analysis 
 The statistical package for the social sciences (SPSS 16.0.1 for Windows) was used 
for statistical analysis. All data were tested for normal distribution with the Kolmogorov-
Smirnov test before further statistical analysis. Since normality could not be assumed, 
differences between groups were assessed using non-parametric Mann-Witney U analysis 
and Spearman correlation tests. Data were displayed as median and range. Categorical data 
were tested by χ2 test. Receiver operating curves (ROC) curves were used to describe the 
relation between increased lactate levels and vital signs and to evaluate their reliability as a 




 In about 50% of possible cases lactate was measured in the pre-hospital setting in 
the Apeldoorn area. The number of measurements was lower in more rural areas (24%). 
Interviews with coordinators in the 4 clusters of the ambulance service revealed consistently 
the same causes of non-compliance and the following barriers were encountered. Duration of 
lactate measurement (60 seconds) resulted in restraint for a successive attempt. In the rural 
areas especially, less frequent calls resulted in less experience in handling the lactate meter. 
Measurement seemed less aggravating for ambulance personnel when for instance patients 
hemodynamics were less deteriorated or when GCS was high or normal. Although personnel 
were well aware of the possible reasons why to change medical acting in the field variation 
from standard protocol (LPA 7) was still an issue. Overall, the majority of ambulance 
personnel experienced inclusion criteria as too strict. An extra measurement was not always 
considered possible in sometimes-stressful situations. On the other hand, occasional 
feedback on particular cases such as repeated lactate measurements in the ED or ICU was 
experienced as positive. 
 
Lactate measurements 
As a result of the implementation of lactate measurement in the pre-hospital setting a 
total 277 ambulance charts were reviewed, allowing evaluation of clinical relevance. Sixty-
one charts did not meet inclusion criteria: forty-one patients were in pre-hospital setting 
diagnosed with seizures, eighteen charts were invalid and two patients were not treated 
according to the national ambulance protocol leaving 216 charts fit for study. Eighty-one 
patients did not meet shock criteria (non-shock group) but 135 patients did (shock group). 
Characteristics of the patients are shown in table 1. 
 The numbers of shock criteria per patient in the shock group were distributed as 
follows: 2 criteria in 55 (40.8%) patients; 3 criteria in 41 (30.6%) patients; 4 criteria in 28 
(20.4%) patients and 5 criteria in 11 (8.1%) patients. In normotensive shock patients (MAP 
60-90mmHg) revealing a lactate ≥ 4mmol/L (n=27) the mortality was higher compared to 
normotensive shock patients with a lactate < 4mmol/L (n=31) (35% vs. 7%; p < 0.001). 
Median lactate in the shock group was significantly higher compared to the non-shock group: 
3.9 (1.5-20.0) mmol/L vs. 2.8 (0.8-7.2) mmol/L (p < 0.0001). In hospital mortality differed 
significantly from the non-shock group: 26.7% in the shock group vs. 1.2% in the control 
group (p < 0.001). 
 In the shock subgroups (subgroup I: lactate < 4 mmol/L, n=74; subgroup II: lactate ≥ 4 
mmol/L, n=61) age and sexes were equally distributed. Median lactate in subgroup I was 3.2 
(1.5-3.9) mmol/L vs. 5.0 (4.0-20.0) mmol / L in subgroup II (p < 0.0001). Compared to 
subgroup I more patients showed an unfavourable respiratory pattern in subgroup II 
(category respiratory rate <10 or >29 breaths / minute) (35.1%vs. 65.6%). Only one patient 
(1.4%) needed intubation in subgroup I but 15 patients  (24.6%) needed intubation in 
subgroup II (p < 0.001). Also significant differences were found in length of stay in intensive 
care unit or critical care unit (LOSICU) (p = 0.03), length of hospital stay (LOSHOSP) (p = 0.04) 
and mortality (subgroup I 12.2% vs. subgroup II 44.3%; p = 0.002). Results within the shock 
group are shown in table 2. 
  
Table 1. Base-line characteristics of non-shock and shock group. 









  Male 
  Female 
Heart rate (beats per minute) 
Mean blood pressure (mmHg) 
Respiratory rate 
        0-9 
        10-29 
        >29 





  Trauma 
  Respiratory failure 
  Cardiac failure (incl. resuscitation) 
  Sepsis / infection 
  Haemorrhage 
  Acute abdomen 
  CNS 

















































































































Data presented as numbers or median (range). * Statistically significant difference. GCS, Glasgow Coma 
Scale; RTS, Revised Trauma Score; CNS, central nervous system; LOSICU/CCU , length of stay in intensive or 
critical care unit; LOSHOSP, length of stay in hospital. 
 
Receiver operating characteristic (ROC) curves were constructed for measurements 
taken in pre-hospital setting. These curves represent the reliability of different values as 
predictors of in-hospital mortality. Area under the curve (AUC) was significantly higher for 
lactate compared to vitals in both the total population (lactate 0.827 vs. SaO2 0.127, MAP 
0.350 and heart rate 0.500; p < 0.01) and the shock group (lactate 0.775 vs. SaO2 0.157, 
MAP 0.421 and heart rate 0.435; p < 0.01). We established a lactate level of 3.2mmol/L as 
the best cut-off point. A lactate level of ≥ 3.2mmol/L was 75% sensitive (95% CI 62-88%) and 
72% specific (62-82%) for prediction of death; figure 1. 
 
Figure 1. ROC curves for mortality prediction in the 
shock group. The AUC was 0.775 for lactate, 0.157 for 
arterial saturation (SaO2), 0.421 for mean arterial 
pressure (MAP) and 0.435 for heart rate (HR). 
Table 2. Base-line characteristics subgroups of shock patients. 
 subgroup I (n=74) 
(lactate < 4 mmol/L) 
subgroup II (n=61) 





  Male 
  Female 
Heart rate (beats per minute) 
Mean blood pressure (mmHg) 
Respiratory rate 
        0-9 
        10-29 
         >29 





  Trauma 
  Respiratory failure 
  Cardiac failure (incl. resuscitation) 
  Sepsis / infection 
  Haemorrhage 
  Acute abdomen 
  CNS 







































































































Data presented as numbers or median (range). * Statistically significant difference. GCS, Glasgow Coma 
Scale; RTS, Revised Trauma Score; CNS, central nervous system; LOSICU/CCU , length of stay in intensive or 
critical care unit; LOSHOSP, length of stay in hospital. 
 
 Discussion 
 Logistical implementation of lactate measurement on the ambulance services means 
implementation of an extra medical act and extra effort. We concluded that this is feasible, 
albeit difficult. One of the reasons for this difficulty is that we aimed at changing behaviour 
without the presence of logistical or procedural errors that often motivate clinical collectives 
to action [15]. Also, involving ED personnel, including consultants may enhance the chance 
of success in a complex and dynamic environment such as the acute care that only can 
function as result of interplay of diverse departments and teams [15,17]. Difficulty with lactate 
measurements in very stressful situations or even ignoring such measurement during these 
events seems reasonable. Lactate measurements are probably less important in patients 
being resuscitated and in need for instant and maximum treatment. In these cases the 
urgency is obvious and will be carried over to the ED personnel. However, during the 
interviews it became clear that for the ambulance personnel lactate measurement in patients 
with less deteriorated hemodynamics seemed less necessary. This is a pity, for lactate 
measurement in the pre-hospital setting could especially be of use in this category of 
patients: i.e. patients being more severely ill than could suspected by vitals only. 
Consequently, a substantial number of patients with prognostically important hypoperfusion 
remain undetected. Most importantly, high lactate levels should trigger for specific 
intervention, i.e. fluid therapy, to improve lactate clearance and to improve outcome[18]. 
Treatment aiming at high lactate clearance is associated with decreased mortality rate in 
severe sepsis patients with elevated baseline lactate but without hypotension [9]. Our results 
seem concordant with the latter finding, i.e. mortality was significantly increased in 
normotensive shock patients if their pre-hospital lactate level was ≥ 4mmol/L (7% vs. 35%). 
Again, this finding is important because those patients would probably not be identified as 
being critically ill in the pre-hospital or ED setting. Recently Howell et al. also found higher 
mortality rates with increased lactate levels (≥4 mmol/L) in normotensive patients. In their 
patient population with suspected infection they confirmed that a single lactate measurement 
was independently predictive of mortality and not a surrogate marker of hypotension [19]. 
Early lactate determination seems helpful for triage decisions, not only in the ED, but also 
before ED presentation. Patients might indeed benefit from advanced activation of medical 
staff in the destination hospital. 
 Several limitations to our observations should be mentioned. First, this quality 
improvement project was not powered to yield conclusions pertaining to the obtained lactate 
measurements. Nevertheless, the data are interesting, since even in this small study strong 
association between lactate and increased morbidity and mortality could be demonstrated. 
This illustrates the importance of measuring lactate in the pre-hospital setting. Still, lactate 
measurements were not compared with the lactate levels in the ED. Consequently, the 
influence of lactate clearance could not be described and the use of the threshold value of 
3.2mmol/L may therefore be of limited value. Second, lactate was measured either from 
venous or capillary blood. Lactate determination in an ED or ICU can be done form venous 
or arterial blood sample and in most previous studies on lactate measurements were done 
arterially. In pre-hospital setting this is however not possible and venous (capillary) samples 
are the first choice. Previous studies showed these measurements to be equivalent [20,21]. 
Finally, the lactate measurements are predominantly performed in the Apeldoorn area and 
thus reflect a single centre observation. Further studies should reveal whether successful 
implementation in several ambulance regions may yield comparable results and if lactate 
measurements in the pre-hospital setting could be used as guideline for treatment. 
 We conclude that implementation of lactate measurement in pre-hospital setting is 
feasible, albeit difficult and potentially clinical relevant. Subsequent studies should evaluate if 
treatment based on pre-hospital lactate measurement will improve outcome. 
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Objective To evaluate whether lactate levels and derived variables are associated with 
organ failure and in-hospital mortality in a mixed intensive care unit (ICU) population. 
 
Methods Retrospective observational study. Case records from 2251 consecutive ICU 
patients admitted between 2001 and 2007 were analyzed. Base line characteristics, all 
lactate measurements, Sequential Organ Failure Assessment (SOFA) scores and in-hospital 
mortality were recorded. The time integral of arterial blood lactate levels above the upper 
normal threshold of 2.2 mmol/L (lactate-time-integral), maximum lactate (max-lactate), and 
time-to-first-normalization, were calculated. Survivors and non-survivors were compared and 
receiver operating characteristic (ROC) analysis were applied. 
 
Results A total of 20755 serum lactate measurements were analyzed. In non-survivors 
(n=405) lactate-time-integral, time-to-normal and cumulative SOFA were higher than in 
hospital survivors (all p<0.001). AUC of ROC curves to predict in-hospital mortality was the 
largest for max-lactate, whereas it was not different among all other lactate derived variables 
(all p>0.05). The area under the ROC curves for admission lactate and lactate-time-integral  
was not different (p=0.36). 
 
Conclusion Cumulative lactate is associated with in-hospital mortality in a heterogeneous 
ICU population. In our patients lactate peak values, but not the time integral of arterial blood 
lactate levels above the upper normal threshold predicted in-hospital mortality. 
Introduction 
Hyperlactataemia is common in critically ill patients and may reflect an imbalance 
between local or systemic oxygen supply (DO2) and oxygen consumption (VO2). 
Hyperlactataemia may also be found during increased aerobic glycolysis in hypermetabolic 
states from various causes [1,2], in patients treated with catecholamines [3,4], as a 
consequence of alkalosis in hyperventilation [5], and with impaired hepatic lactate clearance 
in sepsis or low flow states [6]. Elevated serum lactate levels are associated with the 
development of multiple organ dysfunction (MODS) postoperatively, following trauma, and 
septic shock [7-10] and it has been suggested that hyperlactataemia is associated with 
worse outcome [10-13]. Persistence of lactate levels above normal is associated with higher 
mortality rates in patients with severe sepsis, septic shock [9,14] and in post-cardiac arrest 
patients [15]. We hypothesized that the duration of hyperlactataemia represented by the time 
integral of arterial blood lactate levels above the upper normal threshold of 2.2 mmol/L 
(lactate-time-integral) outperforms single lactate measurements in predicting outcome. 
We therefore retrospectively investigated the relationship between lactate derived 
variables (admission level, maximum level, time-to first-normalization, lactate-time-integral) 
and organ failure, as assessed by the Sequential Organ Failure Assessment (SOFA) score 
[16-18], as well as in-hospital mortality in a large, mixed ICU population. Additionally, we 
performed subgroup analysis on categories in which lactate has been described as predictor 




 A retrospective observational study in a university affiliated teaching hospital where 
the ICU is a mixed, 10 bed “closed format” department. There were no changes in medical 
staff during the study period. Case records from all ICU patients with available serum lactate 
measurements admitted over a 5-year period, January 2002 - December 2006, were 
identified in the ICU database. The study was approved by the Local Ethics Committee that 
waived the need for informed consent. 
 
Data collection 
 Data from all days spent in the ICU were collected retrospectively from the electronic 
patient data monitoring system and the hospital administration database. We collected 
demographic information, diagnosis, acute physiology and chronic health evaluation 
(APACHE II), simplified acute physiology score (SAPS-II), all serum lactate levels, and 
relevant variables for calculation of daily-assessed SOFA score (table 1). Diagnosis 
classifications were based on the APACHE II classifications, hence diagnosis category 
weight [19]. Finally, length of stay in the ICU (ICULOS), days in the hospital before discharge 
(LOSHOSP) and hospital survival were recorded. 
 
Parameters of organ failure 
 SOFA scores were prospectively calculated daily during ICU stay on a routine basis. 
The highest value for each organ system in the preceding 24-hour period was used. If 
variables required for calculation were missing, they were considered as normal until the first 
measured value became available. For any missing value thereafter, the last measured value 
known was used. The following SOFA-derived variables were used: 
1. Initial SOFA score on the first day of ICU admission (from time of admission to 24 
hours following admission, e.g., from 6 am to 6 am the next day). 
2. Cumulative SOFA (cum-SOFA): the sum of all daily SOFA scores during the stay in 
the ICU. 
If the patient received renal placement therapy (RRT) the maximum of 4 points was used for 
the renal component of the SOFA score. 
 
Lactate levels and derived variables 
 Lactate levels were measured in arterial blood using point-of-care blood gas 
analyzers (Rapidlab 865, Siemens, Munich, Germany; upper normal limit 2.2mmol/L). 
The time integral for lactate levels above the upper normal threshold of 2.2 mmol/L was 
calculated during the entire ICU-stay (lactate-time-integral) using custom made software. We 
used a formula that, for practical reasons, assumed a linear change over time between 
measurements. Figure 1 illustrates four possible scenarios used for calculating lactate-time-
integral. Lactate buffer solutions for RRT and continuous epinephrine infusion were not used 
during the study period following the general policy in the unit. 
 
Statistical analysis 
 The statistical package for the social sciences (SPSS 16.0.1 for Windows, Chicago, 
IL, USA) was used for statistical analyses and additional software was used for graphics 
(Prism 5.0 for windows, La Jolla, CA, USA) and comparison of ROC curves (MedCalc 11.2.1, 
Mariakerke, Belgium). Data are presented as mean ± SD or  
 Figure 1. Illustration on calculation of lactate area under the curve above the 
upper normal limit of serum lactate (2.2 mmol/L). The following four equations 
were used in computing lactate-AUC: 
1. AUC A = ((½ · (lactate 0 – lactate 1)) + lactate 1)) · (time 1 – time 0) 
2. AUC B = ((½ · (lactate 2 – lactate 1)) + lactate 1)) · (time 2 – time 1) 
3. AUC C = ((lactate 2 – 2.2)² · (time 3 – time 2)) / 2 · lactate 2 
4. AUC D = ((lactate 4 – 2.2)² · (time 4 – time 3)) / 2 · lactate 4 
 
median [inter-quartile range] as indicated by assessment of normal distribution (D’Agostino-
Pearson omnibus normality test). Wilcoxon rank-sum test was used for categorical data. 
Differences of admission source or admission diagnosis between groups of survivors and 
non-survivors and those with and without hyperlactataemia were assessed using the Chi 
square test. Receiver Operating Characteristic (ROC) curves were used for the assessment 
of sensitivity and specificity of lactate derived variables in predicting in-hospital mortality. 
Areas under the ROC curves (AUCROC) were compared by the method described by DeLong 
et al. [20]. Statistical significance was assumed at p < 0.05. 
 
Results 
Table 1. Baseline and clinical characteristics 
characteristics all 
n = 2251 
surv 
n = 1846 
non surv 




age (yr) 66 (12-98) 69 (57-76) 75 (67-81)  
sex M : F (%) 61 : 39 61 : 39 60 : 40  
SAPS-II 38 (20-113) 33 (24-43) 51 (41-65) < 0.001 
*
 













































vasoactive agent (%) 33 28 57 < 0.001 
* 
LOS ICU (days) 2 (1-5) 2 (1-5) 3 (1-8) < 0.001 
*
 
LOS HOSP (days) 14 (7-27) 15 (9-28) 6 (2-16) < 0.001 
*
 
in hosp mortality (%) 18    
 
Data are presented as numbers and median (interquartile range). AUC, area under the curve; surv, 
survivors; non surv, non-survivors; SAPS-II, simplified acute physiology score; APACHE II, acute 
physiology, age and chronic health evaluation; vasc surg, vascular surgery; abd surg, abdominal 
surgery; resp failure, respiratory failure; GI, gastrointestinal; vasoactive agent: noradrenaline, 
dopamine, dobutamine, phosphodeisterase inhibitor; LOS ICU, length of stay at intensive care; 
LOS HOSP, length of stay at hospital; in hosp mortality, in-hospital mortality; 
a
 survivors vs. non-
survivors, 
*
 Statistically significant difference. Statistics by Chi-square tests 
#
 and Wilcoxon rank-
sum tests. 
  
 During the 5-year period case records of 2251 patients (age 66 [12-98] years; 39% 
female) were identified. A total of 20755 serum lactate measurements were analyzed. 
Median lactate concentration at admission was 1.7 [1.1-2.8] mmol/L; minimum 0.6 mmol/L 
and maximum 27.0 mmol/L. Max-lactate was 2.1 [1.5-3.3] mmol/L, and lactate-time-integral 
0.0 [0.0-244] min·mmol/L. Baseline and clinical characteristics of all patients are summarized 
in table 1 (total population) and table 2 (subgroups). 











age (yr) 69 (60-77) 68 (57-76) 72 (63-78) 37 (24-66) 70 (58-78) 
sex M : F (%) 63 : 37 58 : 42 60 : 40 75 : 25 61 : 38 
SAPS II 48 (37-57) 39 (31-50) 48 (37-63) 24 (17-35) 36 (28-45) 
APACHE II 21 (17-26) 18 (14-22) 22 (16-28) 11 (8-16) 15 (11-19) 
      
heart rate (beats/min) 115 (96-130) 115 (95-130) 110 (80-125) 95 (80-110) 100 (85-115) 
syst BP (mmHg) 105 (80-130) 123 (105-140) 110 (85-140) 123 (105-140) 105 (85-135) 
MAP (mmHg) 58 (50-62) 63 (55-69) 59 (51-65) 65 (58-74) 62 (55-70) 
      
vasoactive agent (%) 56 36 56 20 31 
mech. ventilation (%) 49 47 63 59 36 
      
lactate (mmol/L) 2.4 (1.6-3.9) 1.7 (1.1-2.6) 2.4 (1.4-4.8) 2.0 (1.4-3.2) 1.0 (0-2.1) 
max lactate (mmol/L) 3.0 (2.1-4.9) 2.1 (1.6-2.9) 3.0 (1.9-5.2) 2.3 (1.5-3.3) 1.2 (0-2.8) 
cum-lactate 
(min·mmol/L) 
216 (0-2634) 0 (0-143) 138 (0-1245) 1 (0-243) 0 (0-38) 
in hosp mortality (%) 29 21 38 8 8 
Data are presented as numbers and median (interquartile range). SAPS-II, simplified acute physiology score; APACHE II, 
acute physiology, age and chronic health evaluation 
 In-hospital mortality of our population was 18% and was higher in patients with 
hyperlactataemia during ICU-stay compared to those without hyperlactataemia (26.4% vs. 
10.8%; p < 0.001; table 1). In patients who died in the hospital (n = 405), admission lactate 
(2.6 [1.5-5.0] mmol/L), max-lactate (3.2 [1.9-5.8] mmol/L) and lactate-time-integral (192 [0-
1881] min·mmol/L), were higher than in hospital survivors (n = 1846; admission lactate (1.6 
[1.1-2.5] mmol/L), max-lactate (2.0 [1.4-3.0] mmol/L) and lactate-time-integral 0 [0-134] 























































































































Figure 2. Admission lactate levels (mmol/L), maximum lactate levels (mmol/L), cum-SOFA 
per day (points/day), lactate-time-integral per day ([min·mmol/L]/day) for survivors (n = 
1846) and non-survivors (n = 405); bars show median (upper interquartile range); 
logarithmic scale. 
 
 Figure 3 illustrates the relationship between lactate-time-integral per day and cum-
SOFA per day in survivors (n=1846) and non-survivors (n=405). Geometric means [95% CI] 
of lactate-time-integral per day ([min·mmol/L] / day) and of cum-SOFA per day (points / day) 
were significantly higher in non-survivors (174 [128-236] min·mmol/L / day and 11.1 [10.5-
11.8] points / day) compared to survivors (44 [40-51] min·mmol/L / day and 9.1 [8.9-9.4] 
points / day); both p < 0.001. 
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Figure 3. Relationship between lactate-time-integral per day and cum-SOFA per day 
in both survivors and non-survivors: geometric means (open dot: survivors, closed 
dot: non-survivors) with 95% confidence intervals; logarithmic scale. 
 
 Figure 4 demonstrates the difference between admission lactate levels and lactate-
derived variables with respect to predicting in-hospital mortality. AUCROC for admission 
lactate and lactate-time-integral were similar (0.666 [95% CI 0.646 to 0.686] vs. 0.676 [95% 
CI 0.657 to 0.696]; p=0.36). AUCROC for max-lactate (0.692 [95% CI 0.672 to 0.711]) was 
larger than AUCROC for lactate (0.666 [95% CI 0.646 to 0.686]; p = 0.01) lactate-time-integral 
(0.676 [95% CI 0.657 to 0.696]; p < 0.01), and time to normal (0.552 [95% CI 0.531 to 
0.573]; p < 0.001). The cut-off points derived from the ROC curve for lactate, max-lactate 
and cumulative lactate were 2.7 mmol/L, 2.5 mmol/L and 53 min·mmol/L,  respectively. 
 
Fig. 4 Receiver operating characteristic curves for in-hospital 
mortality prediction. Area under the curve was 0.552 for time to 
normal, 0.666 for lactate, 0.676 for lactate-time-integral and 0.692 
maximum lactate 
 Subgroup analysis revealed similar results. In none of the subgroups (sepsis, n=307; 
cardiac failure, n=213) AUCROC for lactate-time-integral was larger than AUCROC for single 
lactate values. In all subgroups admission lactate and maximum lactate differed between 
survivors and non survivors (all p < 0.001). 
Discussion 
In the present study lactate-time-integral was not superior in predicting in-hospital 
mortality compared to admission or maximum arterial lactate concentrations. Admission 
lactate values, maximum lactate values during ICU stay, and lactate-time-integral, were all 
associated with in-hospital mortality. 
High lactate clearance within the first 6 hours of sepsis is associated with decreased 
60-day mortality, even in the absence of arterial hypotension: survivors compared with non-
survivors had a lactate clearance of 38 vs. 12%, respectively [14]. Recently, in a randomized 
study, the use of lactate clearance was described as an efficacious alternative for ScvO2 
(target > 70%) guided resuscitation of patients in septic shock [21]. However, due to practical 
reasons a treatment bias could not be excluded. Also, difference in protocol actions were 
small: despite a well performed study chance may have influenced the results. In the present 
study we did not look at lactate clearance as described by Nguyen et al, a ratio of lactate 
values, but a combination of the lactate derived variables used may be considered as a 
surrogate. Yet, in the subgroup of patients with sepsis the lactate-time-integral or time to 
normal did not outperform max-lactate. This was the case in a study in which the duration of 
hyperlactataemia, lactime, was the best discriminant of survival when the patients who died 
in the first 24 hours were excluded [10]. We performed a retrospective study and choose not 
to exclude those patients who died early after onset of the disease to picture the influence of 
lactate and lactate derived variables in clinical reality. In conclusion, the present results 
recognize the importance of lactate clearance as described by others but also underline the 
importance of magnitude of lactate values during ICU treatment. 
A serum lactate threshold of ≥ 4 mmol/L has been used to initiate protocol-based 
resuscitation [22,23]. Such an approach might imply acceptance of intermediate serum 
lactate levels in the range of 2 to 4 mmol/L. However, elevated mortality rates are also 
described in critically ill patients with only moderate elevated serum lactate levels during or 
even before admission to the emergency department (ED) [24-26]. Additionally, in two recent 
retrospective studies the relationship between lactate levels, lactate derived variables and 
outcome in critically ill patients was assessed. It was concluded that not only 
hyperlactataemia but also relative hyperlactataemia, i.e. lactate levels in the upper normal 
range, are associated with increased mortality [27,28]. Our results in ICU patients are 
concordant with these results and we believe that normal values provide a reasonable 
clinical sign that tissue oxygenation is adequate and the metabolism is primarily aerobic. 
Nevertheless, it is possible that a higher lactate concentration threshold would have revealed 
different results. In addition, our results suggest that presence of hyperlactataemia 
outperforms its persistence in predicting in-hospital mortality. This might also be explained by 
two other factors. First, the retrospective design of our study and the lack of a specific 
intervention protocol limits the generalisation of our results. Second, arterial lactate 
concentrations not only depend on lactate production but also on its clearance. It is not 
known whether one mechanism is more important than the other with respect to outcome 
prediction. Nevertheless, the mechanism causing hyperlactataemia may play an important 
role in outcome prediction, rather than the hyperlactataemia itself. For instance, as described 
in two recent reports [30,31], the severity of hyperlactataemia due to metformin accumulation 
alone does not predict outcome but even in those cases the causative role is uncertain. Also, 
co morbidities such as renal insufficiency of liver failure may play an additional role [30,31].  
Finally, non-survivors revealed shorter LOSICU and LOSHOSP, whereas lactate-time-
integral was significantly higher in non-survivors compared to survivors. This means that 
non-survivors accumulate enough SOFA points to predict outcome independent of LOSICU as 
illustrated in figure 3. The duration and magnitude of increased serum lactate levels, 
represented by the area under the lactate curve, is associated with final outcome. 
Nevertheless, in the present study the specificity and sensitivity, described by AUCROC, of 
admission lactate and lactate-time-integral were similar in predicting in-hospital mortality. 
 
Several limitations to our observations should be considered. First, this was a 
retrospective study, which precludes definitive conclusions. On top of that, there was no 
predefined lactate measurement or lactate-based goal-directed protocol.  However, we 
consider the results strong enough to warrant further prospective studies analyzing the 
described phenomena, particularly, because the data were collected over a 5 year period 
and derived from a large group of patients. Second, this was a single unit study and therefore 
the results may only reflect the regional population and ICU management strategies. 
Nevertheless, we believe that selection bias was minimized since all consecutive admissions 
were included in the data analysis, since there was no change in medical staffing, and 
admission and discharge criteria were stable during the study period. Third, we assumed a 
linear change in time between two lactate measurements, which is a simplification of a real 
biologic process. However, we believe that our approach represents an approximation with 
acceptable precision for the purpose of the present study. 
 We conclude that lactate load correlated with cumulative SOFA score and is 
associated with in-hospital mortality in a heterogeneous ICU population. Additionally, 
magnitude of serum lactate levels and not necessarily duration of elevated serum lactate 
levels are of value in predicting in-hospital mortality. 
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Purpose To investigate the interchangeability of mixed and central venous-to-arterial carbon 
dioxide differences and the relation between the central venous-to-arterial carbon dioxide 
differences (pCO2 gap) and cardiac index (CI).  We also investigated the value of the pCO2 
gap in outcome prediction. 
 
Methods We performed a post-hoc analysis of a well-defined population of 53 patients with 
severe sepsis or septic shock. Mixed and central venous pCO2 were determined earlier at a 
6-hour interval (T=0 to T=4) during the first 24 hours after intensive care unit (ICU) 
admittance. The population was divided into two groups based on pCO2 gap (cut off value 
0.8 kPa). 
 
Results The mixed pCO2 difference underestimated the central pCO2 difference by a mean 
bias of 0.03 kPa ± 0.32 kPa ( 95% limits of agreement: -0.62 kPa to 0.58 kPa). We observed 
a weak relation between pCO2 gap and CI. The in hospital mortality rate was 21% (6/29) for 
low gap group and 29% (7/24) for high gap group; Odds ratio 1.6 (95% CI 0.5-5.5), p = 0.53. 
At T=4 the Odds ratio was 5.3 (95% CI 0.9-30.7); p=0.08. 
 
Conclusions The central venous pCO2 should not be used as surrogate for the mixed 
venous pCO2 in patients with severe sepsis or septic shock. The likelihood of bad outcome 
enhances when a high pCO2 gap persists after 24 hours of therapy. 
Introduction 
Shock is defined as global tissue hypoxia secondary to an imbalance between 
systemic oxygen delivery (DO2) and oxygen demand (VO2). Global tissue hypoxia as a result 
of systemic inflammatory response or circulatory failure is an important indicator of serious 
illness preceding multiple organ failure. The development of organ failure predicts outcome 
of the septic patient [1]. Unrecognized and untreated global tissue hypoxia increases 
morbidity and mortality: decreased mixed venous oxygen saturation (SvO2) values or central 
venous oxygen saturation (ScvO2) values predict poor prognosis in septic shock [2,3]. 
However, in the majority of patients with severe sepsis or septic shock who are acutely 
admitted to the intensive care unit (ICU) ScvO2 values are >70% [4,5]. Hence, normal ScvO2 
values do not guarantee adequate tissue oxygenation and other circulatory parameters are 
needed to evaluate resuscitation efforts. 
A variable that has been described in this context is the central venous-to-arterial 
carbon dioxide difference (pCO2 gap) [6]. Under physiological conditions, venous-to-arterial 
carbon dioxide difference usually does not exceed 0.8 kPa (6 mmHg) [7] and reflects 
adequacy of venous blood flow, i.e. cardiac output (CO) [8,9]. On macro-circulatory level, an 
inverse relationship between pCO2 gap and cardiac index (CI) has been described in 
critically ill patients [10,11]. Indeed, in patients who fulfilled resuscitation endpoints according 
to international guidelines [1] a cutoff value for pCO2 gap of 0.8 kPa discriminated between 
high and low lactate clearance and CI [6]. Thus, combining ScvO2 values as surrogate for 
global tissue hypoxia and pCO2 gap as surrogate for CI may be useful during resuscitation of 
critically ill patients. However in patients with severe sepsis, on the microcirculatory level 
distributive changes may be independent of CO [12,13]. This means that, on a regional level, 
in accordance to the possibility of persistent tissue hypoxia despite normal ScvO2 levels, 
accumulation of carbon dioxide (CO2) may occur in sepsis despite adequate CO. 
 
 In line with investigations on the agreement between SvO2 and ScvO2, it seems 
useful to determine whether an agreement between  mixed and central venous-to-arterial 
carbon dioxide difference in septic patients exists [5,11]. In other words, are mixed and 
central venous-to-arterial carbon dioxide difference interchangeable? 
 We examined the relationship between central venous-to-arterial carbon dioxide 
difference and CI and we addressed the question whether central venous-to-arterial carbon 
dioxide differences are of additional value in outcome prediction. Additionally, we 
investigated the agreement between mixed and central venous-to-arterial carbon dioxide 




We studied ICU populations in two teaching hospitals: the Martini Hospital 
[Groningen, The Netherlands] (MH) with a 14-bed “closed format” mixed medical / surgical 
ICU department and the Medical Center Leeuwarden [Leeuwarden, The Netherlands] (MCL) 
with a 16-bed “closed format” mixed medical / surgical ICU, including cardiothoracic patients. 
Previously, written informed consent was obtained in all cases from the patient or from the 
patient’s legal representative. The use of earlier obtained data [5] was approved by both 
Local Ethics Committees. 
 
Patients and data collection 
This post-hoc analysis of data from a prospective observational study included a 
population of patients we have described before [5]. All patients were 18 years or older, with 
sepsis or septic shock according to international criteria as the principal reason for ICU 
admittance [14]. Patients were included in case of a clinical indication for additional 
hemodynamic monitoring using a pulmonary artery catheter (PAC) [Criticath SP 5507H TD, 
Becton Dickinson, Singapore] or a Continuous Cardiac Output (CCO) catheter [Arrow 
Deutschland GmbH, Erding, Germany]. The catheter was inserted into an internal jugular or 
subclavian vein according to standard procedure. Position was confirmed by the presence of 
pulmonary artery pressure tracings and chest radiography. Primary data, including 
hemodynamic variables, were collected at 6-hour interval (T0, T1, T2, T3, T4) during the first 
24 hours after acute ICU admittance. Standard blood samples of 2 ml were drawn 
simultaneously from arterial line, distal (pulmonary artery; PA) and proximal / side portal 
(superior caval vein; SCV) from PAC or CCO catheter. To avoid falsely high readings due to 
aspiration of pulmonary capillary blood, aspiration was done gently to avoid high negative 
pressure when blood samples were taken. Blood was sampled from the proximal port of the 
catheter as representative of central venous blood [15,16]. All blood samples were analyzed 
by a point-of-care co-oximeter (Radiometer ABL800 flex, Copenhagen, Denmark) available 
in both ICU’s. The Acute Physiology, Age and Chronic Health Evaluation (APACHE) II-score 
after 24 hours of ICU admittance was calculated [17]. 
 
Statistical analysis 
For analysis the population was divided into two groups: patients with a low pCO2 gap 
(<0.8kPa) vs. patients with a high pCO2 gap (>0.8kPa) at ICU admission (T=0). Statistical 
tests were two-tailed and performed by the statistical package for the social sciences (IBM 
SPSS 19 for Windows, Chicago, IL, USA) or MedCalc software (version 11.2.1, Mariakerke, 
Belgium) for comparing ROC curves. GraphPad software (Prism 5.0, La Jolla, CA, USA) was 
used for graphics. Measurements were not independent but clustered within each patient. All 
data were tested for normal distribution with the D’Agostino-Pearson omnibus normality test 
before further statistical analysis. Differences between both groups were assessed using 
Student’s t-test in case of normal distribution. For categorical data Chi-Square test or 
Fisher’s exact test was used. For each time point (T0-T4) the difference between arterial CO2 
partial pressure (paCO2) and central venous (pvCO2), i.e. pCO2 gap was calculated. Also, for 
each time point the average of CI, mean arterial pressure (MAP), ScvO2, lactate, and infusion 
rate of both norepinephrine and dopamine was calculated. The agreement between CI and 
pCO2 gap was assessed by the mean bias and 95% limits of agreement (mean bias ± 1.96 x 
standard deviation) as described by Bland and Altman (BA) [18]. Pearson correlation 
coefficient between mixed and central venous pCO2 differences was determined. Finally, the 
odds ratio for mortality between patients with a high pCO2 gap and patients with a low pCO2 
gap at both T=0 and T=4 was calculated. Data are displayed as mean ± SD. Statistical 
significance was assumed at p < 0.05. 
 
Results 
 We enrolled 56 patients, of whom three patients were excluded due to lack of data 
(technical problems). We evaluated data from 53 patients with sepsis. Thirty patients were 
enrolled at MCL and 23 patients were enrolled at MH. No complications other than transient 
arrhythmias were observed during the insertion of any catheter. 
 Altogether 245 paired blood samples were obtained. At T=0, 29 patients had a central 
pCO2 difference less than 0.8 kPa (low gap group), and 24 patients had a central pCO2 
difference larger than 0.8 kPa (high gap group). Baseline characteristics and outcome of the 
total population and both groups are shown in table 1. Length of stay at the ICU (LOS ICU) was 
12 ± 10 days and length of stay at the hospital (LOSHOSP) was 25 ± 18 days. 
  
Table 1. Baseline characteristics 
variable total population (n=53) low gap (n=29) high gap (n=24) P value 
# 
age (yr) 66 ± 12 67 ± 13 66 ± 11 0.83 
gender (m/f) 28 / 25 17 / 12 11 / 13 0.41 
1) 
APACHE II 27 ± 8 26 ± 7  27 ± 9 0.70 
diagnosis    0.78 
1) 
  abdominal 25 13 9  
  respiratory 16 10 7  
  urological 5 2 3  
  other 7 4 5  
therapy     
  mechanical ventilation 52 / 53 28 / 29 24 / 24 1.00 
2) 
  RRT 15 / 53 5 / 29 10 / 24 0.08 
2) 
  dopamine (µg/kg/min) 4.1 ± 3.9 3.6 ± 3.5 4.8 ± 2.7 0.41 
  norepinephrine (µg/kg/min) 0.20 ± 0.18 0.23 ± 0.23 0.16 ± 0.19 0.35 
MAP (mmHg) 66 ± 10  68 ± 9 63 ± 11 0.11 
CVP (mmHg) 12 ± 6 12 ± 5 13 ± 6 0.38 
CI (L/min/m
2
) 3.7 ± 1.2 4.1 ± 1.1 3.3 ± 1.1 0.01 
* 
lactate (mmol/L)  3.3± 3.0 2.8 ± 3.1 3.9 ± 2.9 0.19 
ScvO2 (%) 71.8 ± 10.1  74.5 ± 9.3 71.1 ± 7.1 < 0.001 
* 
SvO2 (%) 71.9 ± 10.7  73.2 ± 9.1 70.3 ± 6.6 < 0.01 
* 
pCO2 difference (kPa) 0.70 ± 0.52  0.38 ± 0.42 1.10 ± 0.33 < 0.001 
* 
hematocrit (%)  31 ± 1 30 ± 5 31 ± 6 0.49 
SaO2 (%) 96 ± 2 97 ± 2 96 ± 3 0.37 
pH  7.30 ± 0.10 7.31 ± 0.09 7.29 ± 0.11 0.59 
Data are presented as mean ± SD or as numbers; 
#
 low gap vs. high gap group; APACHE II, acute physiology, age 
and chronic health evaluation; RRT, renal replacement therapy; MAP, mean arterial pressure; CVP, central venous 
pressure; CI, cardiac index; ScvO2, central venous oxygen saturation; SvO2, mixed venous oxygen saturation; 
SaO2, arterial oxygen saturation; 
1)
 Fisher’s exact test; 
2)
 Chi Square test; 
*
 statistically significant difference 
Agreement mixed and central pCO2 difference 
 The mixed pCO2 difference underestimated the central pCO2 difference by a mean 
bias (or absolute difference) of 0.03 ± 0.32 kPa in all paired measurements. The 95% limits 
of agreement ranged from -0.62 to 0.58 kPa (figure 1). Correlation was significant (p < 0.001) 
with Pearson correlation coefficient r of 0.57. Mean delta was not significantly different from 0 
(p = 0.11): both values tend to be equal. This was confirmed by an intra-class coefficient 





























Figure 1. Bland and Altman plots showing the agreement between mixed 
venous pCO2 (PmvCO2) and central venous pCO2 (PcvCO2) at T=0. 
Mean bias 0.03 ± 0.32 kPa; 95% limits of agreement from -0.62 to 0.58 
kPa. 
 
 The results at various time points were similar with at T=0 a mean bias of -0.13 ± 0.40 
kPa and 95% limits of agreement of -1.0 to 0.8 kPa. 
  When the central pCO2 difference was plotted against CI for all paired measurements, 
there was an inverse logarithmic relationship with increasing central pCO2 difference as CI 
decreased (regression equation: CO2gap = 10 
(-0.90 CI + 0.07) ; R2 = 0.07  p < 0.0001; figure 2). 


















Figure 2. Correlation between central venous pCO2 difference and 
cardiac index in total population for all paired measurements at T=0. R
2
 
= 0.07;  p < 0.0001. 
Differences between low gap and high gap group 
 At T=0, low gap group patients had a significantly lower pCO2 gap than patients of the 
high gap group (0.38 ± 0.42 kPa vs. 1.10 ± 0.33 kPa; p < 0.001). There was no significant 
difference between the two groups for age, gender, APACHE II, diagnosis and treatment 
received (table 1). The groups did not differ in both arterial blood pressure with equivalent 
inotropic doses and degree of hyperlactaemia. CI was significantly lower in the high gap 
group (3.3 ± 1.1 L/min/m2 vs. 4.1 ± 1.1 L/min/m2; p = 0.01). 
 Figure 3 shows the evolution in time of the central pCO2 difference and CI. During the 
first 24 hours of treatment there was no significant difference in ScvO2 (except for T=0), 
MAP, and lactate. At all time points, there was no significant difference in either 
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Figure 3. Evolution in time of central pCO2 difference and 
cardiac index for both high gap and low gap group; time 
interval between time points: 6 hours. #, statistically 
significant difference. 
Outcome 
 The hospital mortality rate for all patients was 24.5% (13/53). The in hospital mortality 
rate was 21% (6/29) for low gap group and 29% (7/24) for high gap group; Odds ratio 1.6 
(95% CI 0.5-5.5), p = 0.53. Patients with a central pCO2 difference larger than 0.8kPa at T=4 
had a higher mortality change (n=8; in hospital mortality 38%) compared to patients with a 
central pCO2 difference smaller than 0.8kPa at T=4 (n=39; in hospital mortality 10%): Odds 
ratio 5.3 (95% CI 0.9-30.7); p=0.08. 
 
Discussion 
 We observed a strong agreement between the mixed venous pCO2 and the central 
venous pCO2 differences with seemingly relatively small limits of agreement in patients with 
severe sepsis or septic shock. From a practical perspective, the clinical utility of central pCO2 
values is of potential interest in determining the venous-arterial pCO2 difference. The present 
BA analysis implacably demonstrates a strong agreement between mixed and central 
venous pCO2 differences. This in line with  recent findings by Cuschieri et al. who described 
a mixed population of critically ill patients, including patients with circulatory and cardiogenic 
shock. They observed a minimal but significant difference with slightly higher mean mixed 
pCO2 values compared to mean central pCO2 values (difference 0.02kPa) [11]. Similarly, we 
found a mean delta equal to zero. Despite the practical attractiveness of the abovementioned 
observations, we believe that the 95% limits of agreement (-0.62 to 0.58 kPa; and -1.0 to 0.8 
kPa at T=0) are relatively wide compared to the clinical relevant cutoff value of 0.8 kPa. This 
means that both central venous pCO2 values as well as mixed venous pCO2 values may be 
used for the calculation of a venous-arterial pCO2 difference, but that clinicians should not 
interchange these variables during treatment. 
 We observed a weak but significant inverse logarithmic relation between the pCO2 
gap and global blood flow, i.e. CI, in this specific sepsis population. Indeed, this is in line with 
physiological theory, which describes an inverse curvilineair relation between cardiac output 
and pCO2 difference, according to a modified Fick equation for a range of  CO2-production-
isopleths [19]. Various studies described such an inverse relationship between mixed 
venous-arterial pCO2 difference and CI in septic circulatory failure [20-22]. The increase in 
the venous-arterial pCO2 gradient is explained by a inadequate washout of CO2. Hence, a 
low-flow state is characterized by failure in oxygen delivery to the tissues and excesses of 
CO2 in venous blood. In addition to this, in sepsis an increase in pCO2 difference may persist 
in higher ranges of cardiac output. Due to heterogeneity of microcirculatory blood flow, 
inadequate washout of CO2 in microcirculatory weakunits, despite normal of even elevated 
cardiac output, has been observed during sepsis [12,13].  Vallée et al. [6] tested this 
hypothesis in patients with septic shock, who were supposedly adequately resuscitated at 
the systemic level, with a ScvO2 ≥ 70% [1]. A central venous-arterial pCO2 difference > 6 
mmHg at baseline was inversely correlated with lactate clearance and reduction in SOFA 
score after 24 hours. This might be due to the observed significant lower cardiac index in the 
high gap group, but the normal ScvO2 also points towards the possibility of distributive 
deficits of a normal or elevated systemic blood flow. As expected [4], in our population the 
mean ScvO2 values were higher than 70%. The far majority the patients with a high CO2 gap 
at ICU admittance were in the horizontal part of the cardiac output - CO2 gap curve, indicating 
the relative independence of the two variables in this particular range of systemic blood flow. 
 Finally, the predictive value of the pCO2 difference for outcome is questionable. 
However, a modest time-dependent relationship between an increased pCO2 difference and 
outcome was found. Although not significant, with the persistence of an increased pCO2 
difference the Odds ratio for bad outcome increases. Whether the significantly higher CI and 
ScvO2 in the low pCO2-gap group is causatively related or an epiphenomenon remains topic 
of debate, since protocols that aim for supranormal values have been proven to be harmful in 
critically ill patients [23,24]. 
This study has limitations. First, this is a multicenter, post-hoc study, and its 
observational character has clear limitations. Second, statements about any impact on 
therapeutic intervention are not possible. Third, since all patients were septic, our findings 
may not be generalized to patients less critically ill or to those with other forms of shock. 
Finally, lack of clear insight of treatment prior to ICU admittance at the different EDs or wards 
is a limitation of our study as well. Nevertheless, since we aimed at the usefulness of the 
central venous CO2 difference after ICU admittance, we think these factors are not pertinent 
to the results. 
 
Conclusion 
 Both central venous pCO2 values as well as mixed venous pCO2 values may be used 
for the calculation of a venous-arterial pCO2 difference, but they should not be 
interchangeably during treatment of patients with severe sepsis or septic shock.  
 The central venous pCO2 difference correlates with CI but should not be used to 
estimate CI in patients with severe sepsis and septic shock. 
 A priori, the predictive value for outcome of the central venous pCO2 difference is 
questionable but persistence of an increased central venous pCO2 difference after 24 hours 
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 The majority of patients described in the present thesis were admitted at the various 
hospitals and ICUs with severe sepsis or septic shock. Sepsis is a syndrome characterized 
by infection acompanied by a systemic inflammatory response syndrome (SIRS), i.e. a 
generalized condition which affects the entire body. With increasing seriousness organs fail 
and (relative) hypotension occurs. The complexity of the pathophysiology of sepsis demands 
treatment strategies that covers much more than just the prescription of the right antibiotic to 
eliminate the source, e.g. bacteria. One crucial part of therapy is hemodynamic optimization 
of the patient. This is recognized by the international Surviving Sepsis Campaign by 
embracing the EGDT strategy [1]. Indeed, one can argue on the implementation of a single 
center strategy in international guidelines [2,3] but this discussion may never blur the notion 
of the strategy itself. Of course, goal-oriented manipulation of cardiac preload, afterload and 
contractility, including ScvO2 monitoring is a valuable strategy in a subset of patients. The 
results presented in chapter 2 subscribe this: early identification of patients at risk for 
cardiovascular collapse is important as illustrated by the high mortality rate (57%) in the 
small subset of patients with an initial ScvO2 <50%. Hence, low ScvO2 values do exist early 
after ICU admittance, but apparently its incidence is very low (chapter 2) which makes 
generalized EGDT application a premature activity [2]. However, to ignore a valuable 
strategy such as EGDT at this stage may be an unwise thing to do. EGDT implies early 
recognition of the critically ill patient and enforces continuous reassessment of treatment [4] 
which is probably one of the greatest gains in treating patients with severe sepsis or septic 
shock over the last decade. This also implies that irrespective of proper EGDT treatment the 
clinician should not rest on his or her laurels once several treatment goals have been 
achieved. 
 When a clinician sets several treatment goals, he or she should be aware of the value 
of each goal used. Thus, pursuing abstract numbers without comprehension of their 
relevance should be avoided. It should also not be considered to assume that a ScvO2 value 
of 70% automatically means a SvO2 value of 65% in patients with severe sepsis or septic 
shock. As applies to the trends of both values, the agreement between both absolute values 
is unacceptably wide which means that ScvO2 does not reliably predict SvO2 (chapter 3). The 
difference is not a fixed 5% as stated in many text books and both values should not be 
considered numerically equal. This is not only of academic importance [5] but also clinically 
relevant [6]. If one abandons SvO2 and uses ScvO2 in the resuscitation of critically patients 
one should be aware that also information on pulmonary artery pressures, cardiac filling 
pressures, and cardiac output is disposed. Nevertheless, alternative less invasive 
hemodynamic monitoring devices such as transoesophageal echocardiography, PiCCO, and 
Flo Trac are available [7,8]. With the use of these devices PAC-related complications can be 
avoided [9].  
 The abovementioned lack of agreement between ScvO2 and SvO2 values does not 
exclude the clinical use of both values separately. In line with earlier work [10], ScvO2 values 
in nonsurvivors fell more frequently below the cutoff value of 70% compared to survivors and 
SvO2 values below 65% were more frequently found in nonsurvivors compared to survivors. 
This suggests that after the first hours of resuscitation monitoring of venous oxygen 
saturations could still be clinically relevant. 
 When a central venous access via the jugular or subclavian vein is impossible a 
relatively easy and safe option is central venous access via the femoral vein. The femoral 
central venous line is an adequate route for administration of e.g. antibiotics or 
catecholamines, although the risk for infectious and thrombotic complications should be kept 
in mind [11]. However, it is not an adequate site to obtain data as a surrogate for ScvO2 
values (chapter 4): SfvO2 cannot replace ScvO2. This is not only the case during surgery or 
resuscitation of critically ill patients, including patients with septic shock, but also in stable 
conditions. Thus ease, or incompetence, should never be a surrogate for good data. 
Hopefully the data are convincing enough to abandon such practice in the future. 
 
 Treatment of shock implies improvement of the circulatory state with redistribution of 
flow. Illustratively, four cases are mentioned in chapter 4 in which SfvO2 decreased after six 
hours of treatment while ScvO2 increased. Three out of these four patients died. Although not 
sufficiently powered, this underlines the urgency of shock treatment and the possible 
consequences when a patient does not respond to treatment. 
 Before treatment, (septic) shock should be recognized as early as possible. Delayed 
identification of global tissue hypoxia increases morbidity and mortality. When paramedics 
can recognize critically ill patients better, they will be able not only to start treatment early but 
also to inform ED personnel so appropriate measures can be taken. Vital signs are not 
always accurate enough to detect global tissue hypoxia. Lactate however, rarely transcends 
4 mmol/L in not critically ill patients and lactate also seems a useful additional risk 
stratification tool [14-16]. Fortunately, the implementation of prehospital lactate measurement 
is feasible (chapter 5). Unfortunately, less deteriorated hemodynamics does not trigger the 
average paramedic to obtain a lactate measurement. This makes the implementation difficult 
and strenuous efforts are necessary to train personnel on the use of early lactate 
measurement. The results presented in chapter 5 are in line with earlier findings [17] and 
support the conclusion that early lactate determination is helpful in early triage decisions. 
With the present results in mind should we abolish measurement of vital signs and ignore 
clinical presentation? Absolutely not: one should take both vitals and a lactate into account. 
 In the setting of the ICU it is common practice to take a lactate measurement. 
However, the frequency of measurement varies in clinical practice. Especially during the first 
hours of treatment regular measurements seem useful as part of reassessment. Indeed, 
increased clearance during the first six resuscitation hours means better survival [18]. But 
does the value of lactate evaporate after the first hours of ICU admittance? No: on-going 
watchfulness is the order. Despite equivalent specificities and sensitivities for predicting in-
hospital mortality, not only lactate at admission but also lactate-derived variables were 
significantly different between survivors and nonsurvivors (chapter 6). In addition, 
persistence of hyperlactataemia was associated with organ failure expressed in (cumulative) 
SOFA points. This provides a link to clinical practice and subscribes the use of lactate as a 
risk-stratification tool [16]. 
 How sensitive is lactate as a warning signal for organ failure and outcome? This 
partly depends on the cut off point. The choice in chapter 6 for the threshold of 2.2 mmol/L 
(upper normal limit) was a deliberate one. First, the goal is to ‘normalize’ the patients’ status 
and second, also moderate elevated lactate levels decrease survival chances [1,17,19]. 
Another issue in this context is the mechanism causing hyperlactataemia which is probably 
more important than the hyperlactataemia itself  [20-22]. Hence, the question on predictive 
sensitivity is difficult to answer and maybe not important. Of note, presence of 
hyperlactataemia in ICU patients is important and should encourage the clinician to 
reflection. To put the hyperlactataemia in perspective, the clinical picture, hemodynamics, 
ScvO2, and vital signs should be considered. 
 During treatment of critically ill patients and the regular reassessment of this 
treatment ScvO2 and lactate are useful but not perfect tools. The pCO2 gap described in 
chapter 7 may indeed be a welcome additional application. This variable indirectly estimates 
systemic blood flow and may help to identify the patients who remain inadequately 
resuscitated [23]. When the pCO2 gap is used in clinical practice central venous and mixed 
venous pCO2 values should not be used interchangeably for calculation of venous-arterial 
pCO2 difference: although the 95% limits of agreement seem attractively small, they are 
relatively wide (chapter 7). 
 A high pCO2 gap (> 0.8 kPa or > 6 mmHg) at ICU admission may be indicative for low 
lactate clearance and limited reduction in SOFA score after 24 hours of treatment [23]. On 
top of that, when the pCO2 gap remains high after 24 hours of treatment survival chances 
seem to diminish (chapter 7). However, these results do not warrant the use of pCO2 
difference in future treatment algorithms.  
  Taken together, the following conclusions can be derived from the studies described 
in this thesis: 
o The incidence of low ScvO2 values of acutely admitted critically ill patients is low in 
Dutch ICUs. This is especially true for patients with sepsis or septic shock. 
o In our setting, use of ScvO2-guided resuscitation may only be helpful in a small 
subset of sepsis. 
o Mean SvO2 values and mean ScvO2 values in acutely admitted critically ill patients, 
including patients with severe sepsis or septic shock, are in the normal range in our 
ICUs. 
o ScvO2 does not reliably predict SvO2 in patients with sepsis, independent of sepsis 
origin. 
o The change of ScvO2 compared to the change of SvO2 is not more reliable than the 
exact numerical values in patients with sepsis. 
o SfvO2 cannot replace ScvO2, neither in stable conditions nor during surgery or during 
the resuscitation phase in critically ill patients. 
o The implementation of lactate measurement in pre-hospital setting is feasible and 
potentially clinical relevant, albeit difficult. Subsequent studies should evaluate if 
treatment based on pre-hospital lactate measurement will improve outcome. 
o Persistence of hyperlactataemia is associated with organ failure expressed in 
(cumulative) SOFA points. 
o Lactate load is associated with in-hospital mortality in a heterogeneous ICU 
population. 
o The central venous pCO2 should not be used as surrogate for the mixed venous 
pCO2 in patients with severe sepsis or septic shock. 
o A priori, the predictive value for outcome of the central venous pCO2 difference is 
questionable but persistence of an increased central venous pCO2 difference after 24 
hours of therapy seem to enhance the likelihood of bad outcome in patients with 
severe sepsis or septic shock. 
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 De meerderheid van de patiënten hier beschreven waren op de diverse intensive care 
afdelingen (IC) opgenomen met ernstige sepsis of septische shock. Sepsis is een syndroom 
wat voortkomt uit de reacties van het lichaam, inflammatoire respons, op een infectie; het 
hele lichaam is hierbij betrokken. Bij toenemende ernst zullen organen minder goed gaan 
functioneren zodat zelfs orgaanfalen ontstaat. Indien ook de bloeddruk in bepaalde mate 
daalt wordt gesproken van septische shock. Vanwege de complexiteit van dit ziektebeeld 
vereist de behandeling veel meer dan alleen het voorschrijven en toedienen van een 
antibioticum. Zoals in internationale richtlijnen wordt beschreven, is het optimaliseren van de 
hemodynamiek belangrijk onderdeel van de behandeling. Deze aanbeveling is gebaseerd op 
één, overigens veelbetekende, strategie welke in één ziekenhuis werd uitgevoerd. Men kan 
zich inderdaad de vraag stellen of de letterlijke implementatie van deze strategie in 
internationale richtlijnen gewenst is. De resultaten waren indrukwekkend maar de resultaten 
zijn ook nooit meer in gelijke mate elders behaald. Dit neemt niet weg dat de strategie om 
doelgericht en op geleide van onder andere de centraal veneuze saturatie (ScvO2) de 
cardiale ‘prestatie indicatoren’ (preload, afterload, contractiliteit) te verbeteren (‘Early Goal-
Directed Therapy’, EGDT) wel degelijk een waardevolle strategie is. De resultaten 
beschreven in hoofdstuk 2 bevestigen dit: 57% van de patiënten met een zeer lage ScvO2 
(<50%; normaal waarde 70%) bij opname overleeft de sepsis niet. Dus vroege herkenning 
van de ernstig zieke patiënt met een hoog risico op hemodynamische ineenstorting 
belangrijk zodat daarna tijdens de eerste uren ‘agressief’ behandeld kan worden. 
Desalniettemin komen op Nederlandse IC’s  bij acute opnames van septische patiënten zeer 
weinig lage ScvO2 waarden voor (hoofdstuk 2). Algemene introductie van EGDT lijkt dus 
voorbarig en zullen de resultaten van diverse grote studies verspreid over meerdere centra 
EGDT in perspectief plaatsen. Hiermee wordt niet geïmpliceerd dat EDGT genegeerd moet 
worden, in tegendeel. De arts wordt indachtig EGDT gedwongen de behandeling continue te 
evalueren: op zijn of haar lauweren rusten is er niet bij! Deze geprotocolleerde aanpak is een 
belangrijke vooruitgang in de behandeling van patiënten met ernstige sepsis of septische 
shock.  
 Wanneer een arts bepaalde behandelingsdoelen nastreeft (bijvoorbeeld normalisatie 
van de SvO2) dient hij of zij zich ook bewust te zijn van de waarde van elk doel. Met andere 
woorden, het zonder enig begrip najagen van abstracte getallen (biologische parameters) 
moet worden vermeden. Zo is het eveneens onverstandig bij septische patiënten aan te 
nemen dat een normale ScvO2 (70%) automatisch een normale gemengd veneuze saturatie 
(SvO2) betekent. Beide parameters zijn fysiologisch met elkaar verbonden maar zowel de 
absolute waarden als de trend van beide parameters variëren te veel zodat ScvO2 de SvO2 
niet betrouwbaar inschat (hoofdstuk 3). Dit is niet alleen van enig academisch belang maar is 
ook klinisch relevant. Het vervangen van SvO2 waarden door ScvO2 waarden impliceert dat 
de Swan Ganz katheter (arteria pulmonalis katheter; SG) waarmee de SvO2 wordt gemeten 
in de kast blijft liggen. Hiermee worden de aan SG gerelateerde complicaties uiteraard 
vermeden, maar tegelijkertijd wordt aanvullende informatie (arteria pulmonalis drukken, 
cardiale vullings drukken, slagvolume) over boord gegooid.  
 Hoewel ScvO2 en SvO2 niet elkaars gelijke zijn, kunnen beide parameters nog steeds 
onafhankelijk van elkaar gebruikt worden. Gedurende de eerste 24 uur na IC opname 
werden meer lage ScvO2 en SvO2 waarden gezien bij patiënten die uiteindelijk in het 
ziekenhuis overleden (nonsurvivors) dan bij patiënten die niet overleden (survivors). Dit 
suggereert dat bepaling van veneuze saturaties ook ná de eerste uren relevant kan zijn. 
 Voor het bepalen van ScvO2 of SvO2 is een centraal veneuze toegang via de vena 
jugularis interna of vena subclavia nodig. Wanneer het verkrijgen van een dergelijke toegang 
niet lukt gecontra-indiceerd is  er nog altijd een andere optie: de vena femoralis. Via deze 
route kunnen ook catecholaminen en antibiotica  worden toegediend, waarbij wel het risico 
op mogelijke complicaties (infectie, thrombose) in het achterhoofd moet worden gehouden. 
Echter, voor het vergaren van data als surrogaat voor ScvO2 is deze route ongeschikt: de 
femoraal veneuze saturatie (SfvO2) is geen alternatief voor ScvO2 (hoofdstuk 4). Dit geldt 
niet alleen bij kritisch zieke patiënten of patiënten die een operatie ondergaan maar zelfs ook 
in de poliklinische setting (hoofdstuk 4). Hopelijk zijn de data gepresenteerd in hoofdstuk 4 
overtuigend genoeg om dergelijke praktijken voortaan achterwege te laten. Gemak, of zelfs 
incompetentie, mogen nooit leiden tot onbetrouwbare parameters. 
 Voordat een behandeling van ernstige sepsis of septische shock gestart kan worden 
moet de patiënt met een dergelijk syndroom eerst worden herkend, en liefst zo snel mogelijk. 
Vertraagde herkenning van weefsel hypoxie (globaal zuurstof tekort) leidt tot verhoogde 
morbiditeit en sterfte. Als de ziekte al door paramedici, zoals ambulance personeel, herkend 
kan worden is dat dus winst: de behandeling wordt snel gestart en het personeel op de 
Spoedeisende Hulp (SEH) kan op de komst van een kritisch zieke patiënt worden 
voorbereid. Conventionele parameters (bloeddruk, saturatie, hartslagfrequentie) zijn niet 
altijd accuraat genoeg voor detectie van weefsel hypoxie. Buiten het ziekenhuis worden geen 
centrale lijnen aangelegd en ScvO2 kan hier dus niet gebruikt worden als surrogaat voor 
weefsel hypoxie. Lactaat lijkt een goed alternatief: lactaat is bij niet-kritisch zieke patiënten 
zelden hoger dan 4 mmol/L en lactaat is al beschreven als hulpmiddel om risico op sterfte in 
te schatten op een SEH. Gelukkig is de implementatie van een lactaat bepaling door 
ambulance personeel haalbaar (hoofdstuk 5). Helaas voelt het ambulance personeel zich 
echter niet altijd genegen bij patiënten met nog redelijke conventionele parameters het 
lactaat ook daadwerkelijk af te nemen. Dat is jammer, want juist deze patiënten populatie 
zou gebaat kunnen zijn bij vroege herkenning en behandeling van ziekte. Bovendien verloopt 
de implementatie van lactaat meting in een pre-hospitale setting hierdoor moeizaam. 
Overigens zijn de resultaten beschreven in hoofdstuk 5 geen vrijbrief om de conventionele 
parameters en klinische presentatie van de patiënt te negeren: lactaat kan een belangrijk 
hulpmiddel zijn. 
 Op de IC wordt regelmatig lactaat bepaald. Als onderdeel van een 
behandelingsstrategie om het lactaat binnen 6 uur te normaliseren heeft lactaat zijn reeds 
bewezen. Maar verdampt het nut na de eerste 6 uur? Dit lijkt het niet het geval en continue 
alertheid is het devies want niet alleen het lactaat bij opname is van belang maar ook hogere 
lactaat waarden gedurende het hele verblijf op de IC onderscheiden survivors van 
nonsurvivors (hoofdstuk 7). Bovendien is een verhoogd lactaat geassocieerd met orgaan 
falen uitgedrukt in SOFA score, het eerste teken aan de wand van verslechtering. Hierbij 
moet wel worden opgemerkt dat uiteraard niet alleen naar een verhoogd lactaat 
(hyperlactatemie) moet worden gekeken, maar dat dit ook in perspectief moet worden 
geplaatst. 
 Uit voorgaande blijkt dat zowel ScvO2 als lactaat nuttige parameters zijn tijdens de 
behandeling van kritisch zieke patiënten. Echter, zo is ook gebleken, beide parameters zijn 
niet perfect. In hoofdstuk 7 wordt nog een derde handvat aangereikt: het arterio-veneuze 
pCO2 verschil (pCO2 gap). Met behulp van de pCO2 gap kan een inschatting worden 
gemaakt van de circulatie (lees: bloed flow, slagvolume): een verhoogde pCO2 gap verraadt 
een verlaagd slagvolume. Bovendien kan ook de pCO2 gap worden gebruikt om  nog 
onvoldoende behandelde, maar niet als dusdanig herkende patiënten worden herkend. Voor 
de berekening kunnen zowel de centraal veneuze als gemengd veneuze pCO2 worden 
gebruikt, maar beide getallen mogen niet met elkaar worden verwisseld. Met andere 
woorden: ze zijn niet elkaars gelijke (hoofdstuk 7). Wanneer een verhoogde pCO2 gap na 24 
uur behandeling op de IC verhoogd blijft dan daalt mogelijk de overlevingskans van de 
patiënt: de shock kon niet adequaat genoeg worden bestreden. 
 Uit de hier beschreven studies kunnen de volgende conclusies worden getrokken: 
o Lage ScvO2 waarden komen bij acuut opgenomen septische patiënten weinig voor. 
o Resuscitatie op geleide van ScvO2 lijkt vooral waardevol in een klein deel patiënten 
met ernstige sepsis. 
o ‘Gemiddelde’ SvO2 en ScvO2 waarden bij acuut opgenomen septische patiënten zijn 
normaal in Nederlandse IC’s. 
o ScvO2 is geen betrouwbaar surrogaat voor SvO2 bij septische patiënten; dit geldt niet 
alleen voor de absolute getallen maar ook voor de veranderingen. 
o SfvO2 mag niet gebruikt worden als surrogaat voor ScvO2 bij zowel stabiele cardiale 
poliklinische patiënten, patiënten die chirurgie ondergaan of bij kritisch zieke 
patiënten. 
o Het implementeren van lactaat metingen door ambulance personeel is mogelijk, 
moeizaam maar waarschijnlijk wel klinisch relevant. 
o Voortdurende hyperlactatemie is geassocieerd met orgaan falen, uitgedrukt in SOFA 
score. 
o Lactaat is geassocieerd met sterfte in een heterogene IC populatie. 
o De centraal veneuze pCO2 is geen surrogaat voor de gemengd veneuze pCO2 bij 
patiënten met ernstige sepsis of septische shock. 
o A priori is de voorspellende waarde van het centraal veneuze pCO2 verschil (pCO2 
gap) voor sterfte nihil, maar een persisterend verhoogde pCO2 gap na 24 uur 
behandeling op de IC lijkt de kans op sterfte te verhogen bij patiënten met ernstige 
sepsis of septische shock. 
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Dit proefschrift is het resultaat van een samenwerking met tien afdelingen binnen zeven 
verschillende medische centra. Er zijn dan ook zeer velen aan wie ik veel dank verschuldigd 
ben: u bent mij allen dierbaar. Zonder alle hulp was het simpelweg niet gelukt een dergelijk 
project naast mijn opleiding tot anesthesioloog af te ronden. Het waren achtenzeventig 
buitengewoon interessante maanden waarin tot mijn genoegen het nuttige ook met het 
aangename kon worden verenigd: “Het moet wel leuk blijven!” 
Staat u mij toe een aantal personen bij naam te noemen en hen te bedanken. 
Dr. M.A. Kuiper, beste Michaël, ruim zes jaar geleden sprak jij mij aan over deelname aan 
een onderzoek. Je had een idee en met groot enthousiasme stopte je me een copy in 
handen; ik moest maar eens gaan lezen en nadenken. Dat heb ik gedaan. Sindsdien heb ik 
je leren kennen als een zeer innemend mens en integer clinicus en vorser op wie een 
uitspraak van Confucius wel van toepassing is: “twijfel is de waakhond van het inzicht.” 
Popper had het kunnen zeggen, vind je ook niet? Naast wetenschap is muziek een primaire 
levensbehoefte voor jou en na de uren jazzles op vinyl in jouw muziekkamer groeit ook mijn 
collectie, op CD dat wel, gestaag: dat is genieten!  
Dr. P.E. Spronk, beste Peter, via cyberspace kwam ik voor het eerst in aanraking met jou, 
althans jouw werk, meer bepaald jouw commentaar op mijn wetenschappelijke gespartel. 
Dat was even slikken: niet mals maar wel buitengewoon leerzaam. Na de kennismaking in 
Brussel veranderde jouw commentaar niet maar mijn interpretatie wel. En dat is toch wel 
kenmerkend: jouw motivatie en ongebreideld enthousiasme besprenkeld met een sausje van 
humor werken aanstekelijk. Hoewel mijn hoofd menigmaal tolde van de nieuwe input na een 
bezoekje Apeldoorn reed ik met goede moed weer naar huis in de hoop snel weer eens iets 
“over de schutting te flikkeren”! 
  
Professor dr. T.W.L. Scheeren, beste Thomas, ruim twee jaar geleden heb jij tot mijn 
genoegen de taak van promotor aanvaard. In deze periode heb ik dankbaar gebruik gemaakt 
van jouw kennis en kunde. Ik dank jou niet alleen voor de kritieken maar ook voor 
interessante en vrolijke gesprekken. Gelukkig ziet het er naar uit dat onze wetenschappelijke 
wegen zich voorlopig niet scheiden! 
Dr. J.K.G. Wietasch, beste Götz, uit hoofde van jouw functie als opleider was je al snel 
betrokken bij dit project. Je bleek veel meer dan een opleider en ik dank jou dan ook hartelijk 
voor de logistieke en mentale ondersteuning. Daarnaast was je niet alleen een uiterst 
betrouwbare gesprekspartner maar ook een zeer welkome tafelgast! 
Graag neem ik van de gelegenheid gebruik om de leden van de beoordelingscommissie, 
Prof. Dr. J. Bakker, Prof. Dr. W.F. Buhre en Prof. Dr. M.M.R.F. Struys te bedanken voor de 
tijd en moeite welke zij zich getroost hebben om dit proefschrift te beoordelen.  
Beste paranimfen, Remco en Dedmer, twee grote broers die mij in deze tijden bijstaan: beter 
had ik mij niet kunnen wensen. Dank jullie wel! 
Mijn ouders, Ineke en Henk, ben ik zeer veel verschuldigd. Mede dankzij het warme, stabiele 
nest, alle steun en het onmetelijke geduld ben ik nu niet alleen wie ik ben, maar ook wat ik 
ben, namelijk anesthesioloog en doctor in medische wetenschappen. Liefs en dank! 
Muriël en Kim, Jocelyne en Dorian en Bastiaan: wat mooi en fijn dat jullie familie zijn! 
Anne en Haydée, wat moet ik zonder de morele steun, adviezen en nuchterheid? Helemaal 
niets. Liefs en dank! 
Wandert en Laura: dank voor de lach en getoonde interesse! We moeten maar weer eens zo 
snel mogelijk en zo lang mogelijk tafelen op ons dakterras. 
Alle vrienden en vriendinnen: dank jullie wel, uit de grond van hart hoop ik dat jullie nog lang 
vrienden en vriendinnen zullen zijn! 
Lieve Amber, mijn liefste, vrolijke roerige tijden maken we mee en ondertussen moet ik zo 
nodig iets wetenschappelijks doen…Gelukkig plaats jij alles met een olijke blik of een 
nuchtere opmerking in perspectief. Ik dank je voor de vrolijke noot, het luisterend oor en 
briljante ideetjes, en nog veel meer!  
Lieve Bram, dankzij jou is alles zo heerlijk relatief. Je hebt nu nog geen idee en dat moet je 
misschien maar zo lang mogelijk volhouden. Of doe stiekem net alsof. 
 
 
 
 
